Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 123948-87-8 Chemical Structure| 123948-87-8
Chemical Structure| 123948-87-8

Topotecan

CAS No.: 123948-87-8

Topotecan is an inhibitor oftopoisomerase I and the IC50 values in cancer cells are less than 6 μM.

Synonyms: NSC 609669; SKF 104864A

4.5 *For Research Use Only !

Cat. No.: A144786 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg łÇʶÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1mg

    łÇʶÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Topotecan

CAS No. :123948-87-8
Formula : C23H23N3O5
M.W : 421.45
SMILES Code : O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=CC5=C(CN(C)C)C(O)=CC=C5N=C4C3=C2)=O
Synonyms :
NSC 609669; SKF 104864A
MDL No. :MFCD00870670
InChI Key :UCFGDBYHRUNTLO-QHCPKHFHSA-N
Pubchem ID :60700

Safety of Topotecan

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P501-P270-P264-P301+P310+P330-P405
Class:6.1
UN#:1544
Packing Group:

Related Pathways of Topotecan

DNA

Isoform Comparison

Biological Activity

Target
  • Topo I

    Topo I (DU-145 Luc cells), IC50:2 nM

    Topo I (MCF-7 Luc cells), IC50:13 nM

In Vitro:

Cell Line
Concentration Treated Time Description Reference
A549 cells 100 nM 4 hours suppresses virus-induced genes PMC5193222
RAW 264.7 cells 100 nM suppresses PAMP-induced gene expression PMC5193222
A549-ACE2 cells 100 nM or 500 nM 8 hours and 24 hours suppresses inflaμMatory gene expression PMC8008343
THP1 cells 100 nM or 500 nM 6 hours suppresses inflaμMatory gene expression PMC8008343
U87 cells 1 μM 1, 5, or 10 minutes To evaluate the effect of gefitinib on intracellular topotecan accumulation, results showed that gefitinib significantly increased intracellular accumulation of topotecan. PMC2880208
MT330 cells 1 μM 1, 5, or 10 minutes To evaluate the effect of gefitinib on intracellular topotecan accumulation, results showed that gefitinib significantly increased intracellular accumulation of topotecan. PMC2880208
Myc1 tumorspheres 1 nM–10 µM 72 hours To evaluate the synergistic effect of ABCG2 inhibitor FTC on Topotecan, results showed that FTC reduced the EC50 of Topotecan from 110 nM to 12 nM, significantly inhibiting cell proliferation. PMC4573843
Myc1 tumorspheres 10 nM Topotecan, 10 µM FTC 24, 48, 72 hours To evaluate the effect of Topotecan and FTC combination on apoptosis, results showed that the combination significantly increased apoptosis, especially after 48 and 72 hours. PMC4573843

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
mice lethal inflammation model intravenous injection 20 mg/kg According to the experimental schedule, continued until day 17 preventive inhibition of Top1 activity rescued animals from lethal endotoxic shock PMC5193222
Golden Syrian Hamster SARS-CoV-2 infection model intraperitoneal injection 2.0 mg/kg daily for 30 days suppresses lung inflammation and reduces pathological damage PMC8008343
Mice Colon cancer model Oral 100 μM once daily for 3 days Metronomic topotecan significantly prolonged survival and reduced metastasis. In the adjuvant setting, metronomic maintenance therapy (after FOLFOX-like induction) prolonged survival compared with vehicle controls. PMC3553490
CD1 nude mice U87 and MT330 glioma models Intravenous injection 100 μM Once daily for 4 days To evaluate the effect of gefitinib on the penetration and distribution of topotecan in gliomas, results showed that gefitinib significantly increased intracellular accumulation of topotecan in tumor cells. PMC2880208
CD-1 nude mice G3 MB tumor model Intraperitoneal injection 0.275 mg Every 2 days for 2 weeks To evaluate the effect of Topotecan and ABCG2 inhibitor Ko143 combination on tumor growth and animal survival, results showed that the combination significantly suppressed tumor growth and prolonged survival. PMC4573843

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00259935 Lung Cancer, Small Cell Phase 1 Completed - United States, New Hampshire ... More >> GSK Investigational Site Lebanon, New Hampshire, United States, 03756 United States, New York GSK Investigational Site Bronx, New York, United States, 10461 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 United States, West Virginia GSK Investigational Site Morgantown, West Virginia, United States, 26506 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1066 CX GSK Investigational Site Utrecht, Netherlands, 3584 CX Less <<
NCT00502762 Lung Cancer R... More >>efractory to Chemotherapy Less << Phase 2 Unknown August 2007 Korea, Republic of ... More >> Gachon University Gil Medical Center Incheon, Korea, Republic of, 405 760 Less <<
NCT01039025 Myeloma Phase 2 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00098956 Extensive Stage Small Cell Lun... More >>g Cancer Recurrent Small Cell Lung Cancer Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00098956 - Completed - -
NCT00436644 Ovarian Cancer ... More >> Peritoneal Cavity Cancer Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Arizona Scottsdale, Arizona, United States, 85254 United States, Florida Mayo Clinic in Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT03289910 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Chronic Myelomonocytic Leukemia Essential Thrombocythemia Myelodysplastic/Myeloproliferative Neoplasm Myelofibrosis Polycythemia Vera Recurrent Adult Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Less << Phase 2 Recruiting June 1, 2020 United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Site Public Contact    410-955-8804    jhcccro@jhmi.edu    Principal Investigator: Keith W. Pratz Less <<
NCT02684071 Recurrent Childhood Medullobla... More >>stoma Recurrent Childhood Ependymoma Childhood Atypical Teratoid/Rhabdoid Tumor Embryonal Tumor With Abundant Neuropil and True Rosettes Metastatic Malignant Neoplasm to the Leptomeninges Less << Phase 2 Recruiting February 2020 United States, Florida ... More >> Nicklaus Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Ziad A Khatib, MD    305-662-8386    ziad.khatib@mch.com    Contact: Matthew Bittle, Supervisor    786-624-2838    matthew.bittle@nicklaushealth.org    Sub-Investigator: John Ragheb, MD          Sub-Investigator: Guillermo De Angulo, MD          Sub-Investigator: Sanjiv Bhatia, MD          Sub-Investigator: Toba Niazi, MD          Sub-Investigator: David Sandberg, MD          Sub-Investigator: Ana Diaz, ARNP          Principal Investigator: Ziad A Khatib, MD Less <<
NCT02390843 Retinoblastoma ... More >> Clear Cell Sarcoma Renal Cell Carcinoma Rhabdoid Tumor Wilms Tumor Hepatoblastoma Neuroblastoma Germ Cell Tumors Ewings Sarcoma Non-rhabdomyosarcoma Soft Tissue Sarcoma Osteosarcoma Rhabdomyosarcoma Less << Phase 1 Recruiting February 2021 United States, Georgia ... More >> Children's Healthcare of Atlanta/Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Amy Autry-Bush    404-785-6011    amy.autry-bush@choa.org    Principal Investigator: Kelly Goldsmith, MD          Sub-Investigator: William T Cash, MD Less <<
NCT00436644 - Completed - -
NCT00812266 Extensive Disease ... More >> First-Line Small Cell Lung Cancer Less << Phase 3 Terminated(Slow accrual) - Denmark ... More >> Dept. Oncology, Rigshospitalet Copenhagen, Denmark Less <<
NCT00005811 AIDS-related Diffuse Large Cel... More >>l Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma AIDS-related Diffuse Small Cleaved Cell Lymphoma AIDS-related Immunoblastic Large Cell Lymphoma AIDS-related Lymphoblastic Lymphoma AIDS-related Peripheral/Systemic Lymphoma AIDS-related Primary CNS Lymphoma AIDS-related Small Noncleaved Cell Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma HIV-associated Hodgkin Lymphoma Leptomeningeal Metastases Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Medulloblastoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01654965 Adult Solid Neoplasm Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01012817 Metastatic Malignant Solid Neo... More >>plasm Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Unresectable Solid Neoplasm Less << Phase 1 Phase 2 Suspended(Other - assess toxic... More >>ity and perform interim analysis.) Less << - United States, Arizona ... More >> Mayo Clinic Hospital Phoenix, Arizona, United States, 85054 Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, California University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Colorado University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States, 60451 University of Chicago Medicine-Orland Park Orland Park, Illinois, United States, 60462 United States, Kansas University of Kansas Clinical Research Center Fairway, Kansas, United States, 66205 United States, Kentucky University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas Parkland Memorial Hospital Dallas, Texas, United States, 75235 UT Southwestern/Simmons Cancer Center-Dallas Dallas, Texas, United States, 75390 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT01500720 Small Cell Lung Cancer Phase 2 Completed - -
NCT00466232 Small Cell Carcinoma ... More >> Lung Cancer Less << Phase 1 Completed - United States, Minnesota ... More >> Park Nicollet Institute St. Louis Park, Minnesota, United States, 55416 Less <<
NCT01500720 - Completed - -
NCT00484666 Ovarian Cancer Phase 2 Completed - United States, Virginia ... More >> Carilion GYN Oncology Associates Roanoke, Virginia, United States, 24014 Less <<
NCT00114166 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - -
NCT00170677 Ovarian Cancer Phase 2 Completed - Germany ... More >> Charité Campus Virchow-Klinikum Berlin, Germany, 13533 Less <<
NCT00114166 - Completed - -
NCT00287911 Cervical Cancer Phase 1 Completed - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00313612 - Terminated - -
NCT00313612 Recurrent Ovarian Epithelial C... More >>ancer Less << Phase 2 Terminated - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 NYU Cancer Institute New York, New York, United States, 10016 Less <<
NCT00231855 Ovarian Neoplasms ... More >> Uterine Neoplasms Less << Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10461 Less <<
NCT00343044 Ovarian Cancer ... More >> Fallopian Tube Cancer Peritoneal Cancer Less << Phase 2 Completed - United States, Washington ... More >> Virginia Mason Medical Center Seattle, Washington, United States, 98101 Puget Sound Oncology Consortium (PSOC) Seattle, Washington, United States, 98104 Less <<
NCT00343044 - Completed - -
NCT00046111 Lung Cancer, Small Cell ... More >> Solid Tumor Cancer Less << Phase 1 Completed - United States, New York ... More >> GSK Investigational Site New York, New York, United States, 10021 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 Canada, Ontario GSK Investigational Site Ottawa, Ontario, Canada, K1H 1C4 Less <<
NCT00319969 Small Cell Lung Cancer Phase 2 Completed - -
NCT00437307 Ovarian Cancer PHASE3 COMPLETED 2025-06-15 Charité Campus Virchow Kliniku... More >>m, Berlin, 13353, Germany Less <<
NCT01004874 Malignant Glioma ... More >> Glioblastoma Gliosarcoma Less << Phase 2 Active, not recruiting December 2018 United States, North Carolina ... More >> The Preston Robert Tisch Brain Tumor Center at Duke Durham, North Carolina, United States, 27710 Less <<
NCT00087126 Cervical Cancer Phase 2 Completed - -
NCT01004874 - Active, not recruiting - -
NCT00477282 Ovarian Cancer Phase 3 Completed - -
NCT00287859 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 1 Terminated(Withdrawn due to lo... More >>w accrual) Less << - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT01904253 Small Cell Lung Cancer (SCLC) Phase 2 Terminated(The preliminary dat... More >>a does not suggest any safety signal, but an ad hoc interim analysis showed an imbalance of PFS between the two arms) Less << - Germany ... More >> Klinikum Mannheim GmbH Universitaetsklinikum Mannheim, Baden-Württemberg, Germany Lungenklinik Heckeshorn- HELIOS Kliniken GmbH Berlin, Germany LungenClinic Grosshansdorf Grosshansdorf, Germany Klinikum Koeln-Merheim Koplin, Germany St. Hildegardis-Krankenhaus- Katholisches Klinikum Mainz Mainz, Germany LMU-Campus Innenstadt Muenchen, Germany Italy Azienda Ospedaliero-Universitaria S. Luigi Gonzaga Orbassano, Turin, Italy IRCCS Centro di Riferimento Oncologico di Aviano, Divisione Oncologia Medica A Aviano, Italy Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari Bari, Italy Azienda Ospedaliera Univ. Policlinico Gaspare Rodolico Catania, Italy Azienda Ospedaliera Instituti Ospitalieri di Cremona Cremona, Italy Azienda Ospedaliera Universitaria Careggi Firenze, Italy IEO Istituto Europeo di Oncologia Milano, Italy Azienda Ospedaliera San Gerardo U.O Oncologia Medica Monza, Italy Arcispedale S. Maria Nuova Azienda Ospedaliera di Reggio Emilia Reggio Emilia, Italy A.O.V.V. Ospedale Eugenio Morelli-Sondalo Sondalo, Italy Japan National Cancer Center Hospital East Chiba, Japan, 277-8577 National Kyushi Cancer Center Fukuoka, Japan, 811-1395 Hyogo Cancer Center Hyogo, Japan, 673-8588 Saitama Cancer Center Saitama, Japan, 362-0806 Shizuoka Cancer Center Shizuoka, Japan, 411-8777 Nippon Medical School Hospital Tokyo, Japan, 113-8603 Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo, Japan, 135-8550 Less <<
NCT00770536 Cancer Carcin... More >>oma Fallopian Tube Cancer Gynecological Malignancies Metastases Oncology Ovarian Cancer Solid Tumors Tumors Less << Phase 1 Completed - United States, Arizona ... More >> Research Site Tucson, Arizona, United States, 85724-5024 United States, California Research Site Sacramento, California, United States, 95817 United States, Florida Research Site Orlando, Florida, United States, 32806 Research Site Tampa, Florida, United States, 33612 United States, Minnesota Research Site St. Louis Park, Minnesota, United States, 55426 United States, North Carolina Research Site Winston Salem, North Carolina, United States, 27103 United States, North Dakota Research Site Bismarck, North Dakota, United States, 58501 United States, Ohio Research Site Columbus, Ohio, United States, 43219 United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States, 19111 Australia, South Australia Research Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Research Site Footscray, Victoria, Australia, 3011 Research Site Parkville, Victoria, Australia, 3050 Belgium Research Site Leuven, Belgium, 3000 Research Site Liège, Belgium, 4000 Research Site Liège, Belgium, 4000 Research Site Wilrijk, Belgium, 2610 Less <<
NCT00828139 Extensive Stage Small Cell Lun... More >>g Cancer Recurrent Small Cell Lung Cancer Less << Phase 2 Completed - -
NCT01417806 Small Cell Lung Cancer Phase 2 Unknown December 2016 United States, Florida ... More >> VA. Medical Center Recruiting Miami, Florida, United States, 33125 Contact: Niramol Savaraj, M.D.    305-575-3143    nsavaraj@med.miami.edu    Contact: Vy Dinh, M.D.    305-575-3143    vdinh@med.miami.edu    Principal Investigator: Niramol Savaraj, M.D. Less <<
NCT00390806 Lung Cancer, Non-Small Cell Phase 3 Completed - -
NCT00322920 Cervix Cancer Phase 1 Terminated(Low accrual) - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less <<
NCT00305942 Carcinoma, Small Cell Phase 2 Completed - United States, Alabama ... More >> Northeast Alabama Regional Medical Center Anniston, Alabama, United States, 36207 United States, Arkansas Northeast Arkansas Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Graves-Gilbert Clinic Bowling Green, Kentucky, United States, 42101 Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Louisiana Hematology Oncology Life Center Alexandria, Louisiana, United States, 71301 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Montana Montana Cancer Institute Foundation Missoula, Montana, United States, 59802 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Associates in Hematology Oncology Chattanooga, Tennessee, United States, 37404 Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00194935 Ovarian Cancer PHASE2 TERMINATED 2025-08-06 Weill Medcial College of Corne... More >>ll University, New York, New York, 10021, United States Less <<
NCT00322751 Lung Cancer PHASE1 COMPLETED 2025-11-09 University of New Mexico, Albu... More >>querque, New Mexico, 87131, United States Less <<
NCT00828139 - Completed - -
NCT01405235 Recurrent, Persistent or Metas... More >>tasized Cervical Cancer Less << Phase 3 Unknown January 2015 Germany ... More >> Universitätsfrauenklinik Erlangen, Bavaria, Germany, 91054 Less <<
NCT00109798 Central Nervous System Tumors ... More >> Lymphoma Less << Not Applicable Withdrawn(Sub-Investigator rel... More >>oacted to another institution) Less << - -
NCT00325416 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00112619 Brain and Central Nervous Syst... More >>em Tumors Carcinoma of Unknown Primary Leukemia Lymphoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Terminated(Slow accrual and co... More >>mpany withdrawing support to supply the drug) Less << - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00390806 - Completed - -
NCT00325416 - Completed - -
NCT00732420 Solid Tumours Phase 1 Completed - United States, Pennsylvania ... More >> GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1066 CX GSK Investigational Site Utrecht, Netherlands, 3584 CX Less <<
NCT00215956 Rectal Neoplasms Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01803269 Extensive Stage Small Cell Lun... More >>g Cancer Recurrent Small Cell Lung Cancer Less << Phase 2 Terminated(Due to lack of acti... More >>vity and slow accrual) Less << - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Decatur Memorial Hospital Decatur, Illinois, United States North Shore University Health System Evanston, Illinois, United States Ingalls Memorial Hospital Ingalls Park, Illinois, United States Illinois Cancer Care Peoria, Illinois, United States Less <<
NCT00698516 Recurrent Small-cell Lung Canc... More >>er (SCLC) Lung Cancer, Small Cell Less << Phase 2 Completed - United States, Arkansas ... More >> GSK Investigational Site Jonesboro, Arkansas, United States, 72401 United States, Florida GSK Investigational Site Gainesville, Florida, United States, 32605 GSK Investigational Site Naples, Florida, United States, 34119 United States, Georgia GSK Investigational Site Athens, Georgia, United States, 30607 GSK Investigational Site Macon, Georgia, United States, 31201 GSK Investigational Site Marietta, Georgia, United States, 30060 United States, Mississippi GSK Investigational Site Jackson, Mississippi, United States, 39202 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45236 United States, South Carolina GSK Investigational Site Mt. Pleasant, South Carolina, United States, 29464 United States, Tennessee GSK Investigational Site Chattanooga, Tennessee, United States, 37404 GSK Investigational Site Memphis, Tennessee, United States, 38104 GSK Investigational Site Memphis, Tennessee, United States, 38120 GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Fort Worth, Texas, United States, 76104 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98101-2795 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53792 Less <<
NCT00698516 - Completed - -
NCT00682279 Advanced Solid Tumors Phase 1 Withdrawn(Cancelled before enr... More >>ollment) Less << March 2011 United States, Minnesota ... More >> GSK Investigational Site Rochester, Minnesota, United States, 55905 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00305942 - Completed - -
NCT00842452 Cervical Cancer ... More >> Endometrial Cancer Fallopian Tube Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer Less << Phase 1 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT00547651 Small Cell Lung Cancer Phase 3 Completed - -
NCT02514447 Small Cell Lung Cancer Phase 1 Phase 2 Active, not recruiting August 2019 -
NCT01840943 - Terminated(the study was termi... More >>nated due to medication supply issue from current manufacturer) Less << - -
NCT00770731 Advanced Cancer Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01683149 Solid Tumor Phase 1 Completed - United States, California ... More >> Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Connecticut Connecticut Childrens Medical Center Hartford, Connecticut, United States, 06106 United States, Delaware Nemours/Alfred I. duPont Hospital for Children, Delaware Wilmington, Delaware, United States, 19803 United States, Florida University of Florida, Gainesville Gainesville, Florida, United States, 32610 Nemours Children's Clinic, Jacksonville Jacksonville, Florida, United States, 32207 University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 All Children's Hospital, St. Petersburg St. Petersburg, Florida, United States, 33701 United States, New York Montefiore Medical Center, Children's Hospital at Montefiore Bronx, New York, United States, 10467 United States, Utah Primary Children's Medical Center/Utah Salt Lake City, Utah, United States, 84113 Less <<
NCT00317772 Ovarian Cancer ... More >> Peritoneal Neoplasms Fallopian Tube Cancer Less << Phase 1 Phase 2 Active, not recruiting September 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00308165 Brain Neoplasms, Primary Malig... More >>nant Less << Phase 1 Phase 2 Unknown December 2015 United States, New York ... More >> Columbia University Medical Center Neurological Institute New York, New York, United States, 10032 Less <<
NCT00674674 Neoplastic Meningitis Phase 1 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00516438 Malignant Solid Tumors Phase 1 Completed - United Kingdom ... More >> Research Site Glasgow, United Kingdom Research Site Leicester, United Kingdom Research Site Manchester, United Kingdom Less <<
NCT00365547 - Completed - -
NCT01840943 Epithelial Ovarian Cancer Phase 3 Terminated(the study was termi... More >>nated due to medication supply issue from current manufacturer) Less << - China ... More >> Beijing, China Chang Sha, China Guangzhou, China Jinan, China Nanjing, China Nanning, China Wuhan, China Less <<
NCT02100007 Solid Tumors Phase 1 Phase 2 Terminated(lack of efficacy) - United States, Arizona ... More >> Pinnacle Oncology Hematology Scottsdale, Arizona, United States, 85258 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203 United States, Washington University of WA Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 United Kingdom The Bays St Mary's Hospital London, England, United Kingdom, W2 1NY Sarah Cannon Research Instititute UK London, England, United Kingdom, WIG 6AD Less <<
NCT03227016 Small Cell Lung Cancer SCLC Phase 1 Recruiting August 2020 Germany ... More >> Klinik München Gauting Recruiting München Gauting, Germany Contact: Joachim von Pawel, MD Less <<
NCT00960739 Neuroblastoma Phase 2 Completed - France ... More >> Centre Oscar Lambret Lille, France, 59020 Centre Léon Bérard Lyon, France, 69373 Hôpital des Enfants Toulouse, France, 31059 Less <<
NCT02100007 - Terminated(lack of efficacy) - -
NCT00365547 Lung Cancer Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Park Nicollet Cancer Center Saint Louis Park, Minnesota, United States, 55416 Less <<
NCT00918320 Neuroblastoma ... More >> Brain Tumors Solid Tumors Less << Phase 2 Completed - France ... More >> Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT03061812 Small Cell Lung Cancer Phase 3 Recruiting September 30, 2021 -
NCT00697476 Small Cell Lung Cancer Phase 1 Phase 2 Terminated(insufficient enroll... More >>ment) Less << - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00720096 Ovarian Cancer Not Applicable Terminated(Funds for this proj... More >>ect have been spent, and it is thereby terminated.) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT03154996 Gliomas Phase 1 Recruiting September 2021 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Laura Good, RN       lg2824@cumc.columbia.edu    Principal Investigator: Jeffery Bruce, MD Less <<
NCT00294190 Small Cell Lung Cancer|Carcino... More >>ma, Small Cell Less << PHASE2 COMPLETED 2025-07-09 Northeast Arkansas Clinic, Jon... More >>esboro, Arkansas, 72401, United States|Florida Cancer Specialists, Fort Myers, Florida, 33901, United States|Watson Clinic Center for Cancer Care and Research, Lakeland, Florida, 33805, United States|Florida Hospital Cancer Institute, Orlando, Florida, 32804, United States|Northeast Georgia Medical Center, Gainesville, Georgia, 30501, United States|Consultants in Blood Disorders and Cancer, Louisville, Kentucky, 40207, United States|Hematology Oncology Life Center, Alexandria, Louisiana, 71301, United States|Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, 49503, United States|Methodist Cancer Center, Omaha, Nebraska, 68114, United States|Oncology Hematology Care, Cincinnati, Ohio, 45242, United States|Spartanburg Regional Medical Center, Spartanburg, South Carolina, 29303, United States|Chattanooga Oncology Hematology Associates, Chattanooga, Tennessee, 37404, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37023, United States Less <<
NCT00703807 Endometrial Cancer Phase 1 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT02357810 Adult Liposarcoma ... More >> Metastatic Liposarcoma Metastatic Osteosarcoma Recurrent Adult Soft Tissue Sarcoma Recurrent Liposarcoma Recurrent Osteosarcoma Stage IV Adult Soft Tissue Sarcoma Less << Phase 2 Recruiting June 2020 United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Kelly K. Curtis    480-301-8335    curtis.kelly1@mayo.edu    Principal Investigator: Kelly K. Curtis          United States, Florida Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Steven Attia    904-953-2558    attia.steven@mayo.edu    Principal Investigator: Steven Attia          United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Mark Agulnik    312-695-1222    m-agulnik@northwestern.edu    Principal Investigator: Mark Agulnik          Northwestern University- Lake Forest Hospital Recruiting Lake Forest, Illinois, United States, 60045 Contact: Valerie Nelson, MD    847-582-2134       Principal Investigator: Valerie Nelson, MD          United States, Iowa University of Iowa Hospitals and Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Mohammed M. Milhem    319-356-2324    mohammed-milhem@uiowa.edu    Principal Investigator: Mohammed M. Milhem          United States, Minnesota Masonic Cancer Center, University of Minnesota Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Keith M. Skubitz    612-625-5109    skubi001@umn.edu    Principal Investigator: Keith M. Skubitz          Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Scott H. Okuno    507-284-4849    okuno.scott@mayo.edu    Principal Investigator: Scott H. Okuno          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Brian A. Van Tine    314-747-8475    bvantine@dom.wustl.edu    Principal Investigator: Brian A. Van Tine          United States, Wisconsin University of Wisconsin Hospital and Clinics Not yet recruiting Madison, Wisconsin, United States, 53792 Contact: Thomas A. McFarland    608-265-3890    Thomas.mcfarland@uwmf.wisc.edu    Principal Investigator: Thomas A. McFarland Less <<
NCT00720096 - Terminated(Funds for this proj... More >>ect have been spent, and it is thereby terminated.) Less << - -
NCT00483860 Solid Tumours PHASE1 COMPLETED 2012-02-06 GSK Investigational Site, Scot... More >>tsdale, Arizona, 85258, United States|GSK Investigational Site, Lebanon, New Hampshire, 03756, United States|GSK Investigational Site, Seoul, 110-744, Korea, Republic of|GSK Investigational Site, Seoul, 120-752, Korea, Republic of|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Utrecht, 3584 CX, Netherlands Less <<
NCT01492673 Neuroblastoma ... More >> Sarcoma Less << Phase 2 Completed - United States, Arizona ... More >> Phoenix Children'S Hospital Phoenix, Arizona, United States, 85016 United States, Colorado University of Colorado Health Sciences Center and The Children's Hospital Denver, Colorado, United States, 80045 United States, Florida MD Anderson Cancer Center Orlando at Arnold Palmer Hospital for Children Orlando, Florida, United States, 32806 United States, Missouri Children's Mercy Hospital & Clinics Kansas City, Missouri, United States, 64108 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania Pennsylvania State University College of Medicine Hershey, Pennsylvania, United States, 17110 Canada, Alberta Alberta Children'S Hospital Calgary, Alberta, Canada, T2N 1N4 Less <<
NCT02200757 Metastatic Small Cell Lung Can... More >>cer Less << Phase 2 Unknown July 2017 -
NCT02980809 Small Cell Lung Cancer Phase 2 Not yet recruiting March 2020 -
NCT01497873 Small Cell Lung Cancer Phase 2 Unknown December 2017 Korea, Republic of ... More >> Chungbuk University Hospital Recruiting Daegu, Korea, Republic of Contact: Ki Hyung Lee    82-43-269-6015       Keimyung University Dongsan Center Recruiting Daegu, Korea, Republic of Contact: Hong Suk Song    82-53-250-7436       National Cancer Center Recruiting Goyang, Korea, Republic of, 410-769 Contact: Heung Tai Kim    82-31-920-1622       Principal Investigator: Heung Tai Kim          Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Sang We Kim    82-2-3010-3215       Chung-Ang University hospital Recruiting Seoul, Korea, Republic of Contact: Joung Soon Jang    82-2-6299-1427       Kyung Hee University Medical Hospital Recruiting Seoul, Korea, Republic of Contact: Jae Heon Jeong    82-2-958-8723       Seoul National University Boramae Medical Center Recruiting Seoul, Korea, Republic of Contact: Jin Soo Kim    82-2-870-3202       Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Dong Wan Kim    82-2-2072-2995       Seoul St. Marys Hospital Recruiting Seoul, Korea, Republic of Contact: Jin Hyoung Kang    82-2-2258-2680       Seoul Veterans Hospital Recruiting Seoul, Korea, Republic of Contact: Bong Seog Kim    82-2-2225-1319       Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Hye Ryeon Kim    82-10-8713-4793       Ajou University Hospital Recruiting Suwon, Korea, Republic of Contact: Jin Hyuk Choi    82-31-219-4920       St. Vincents Hospital Recruiting Suwon, Korea, Republic of Contact: Hoon Kyo Kim    82-2-540-7935 Less <<
NCT00888810 Cancer Ovaria... More >>n Relapse Chemotherapy Less << Phase 2 Terminated(lack of efficacy (i... More >>ntermediate analysis)) Less << - France ... More >> Centre François Baclesse Caen, Calvados, France, 14076 Centre Paul Papin Angers, France, 49933 CHU Jean MINJOZ Besancon, France, 25030 Institut Bergonié Bordeaux, France, 33076 Centre G-F Leclerc Dijon, France, 21076 CHD Les Oudairies La ROCHE SUR YON, France, 85025 Centre Jean Bernard Le MANS, France, 72015 Centre Val d'Aurelle Montpellier, France, 34298 Centre azuréen de cancérologie Mougins, France, 06250 Centre Alexis vautrin Nancy, France, 54511 Centre Catherine de Sienne Nantes, France, 44202 Centre René Gauducheau Nantes, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Hôpital Diaconesses Paris, France, 75012 Institut CURIE Paris, France, 75231 APHP Hopital TENON Paris, France, 75970 Institut Jean Godinot Reims, France, 51056 Institut de Cancérologie de la Loire Saint Etienne, France, 42271 Centre Paul Strauss Strasbourg, France, 67065 Institut Claudius regaud Toulouse, France, 31052 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00315211 Mediastinal Neoplasms Phase 2 Terminated(Slow Accrual) - United States, Ohio ... More >> Aultman Hospital Canton, Ohio, United States, 44710 Less <<
NCT02487095 Carcinoma, Non-Small -Cell Lun... More >>g Ovarian Neoplasms Small Cell Lung Carcinoma Uterine Cervical Neoplasms Carcinoma, Neuroendocrine Extrapulmonary Small Cell Cancer Less << Phase 1 Phase 2 Recruiting October 30, 2025 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00382733 Tumors Phase 1 Phase 2 Completed - United States, Tennessee ... More >> The West Clinic Memphis, Tennessee, United States, 38120 Less <<
NCT00610571 Glioblastoma ... More >>Gliosarcoma Anaplastic Astrocytoma Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT02348398 Cervical Cancer Phase 2 Withdrawn - -
NCT01630018 Epithelial Ovarian Cancer Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Seoul Metropolitan, Korea, Republic of Less <<
NCT01466855 Retinoblastoma Not Applicable Terminated(Competing studies) - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00361803 Cancer Phase 1 Completed - United States, Arizona ... More >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 Less <<
NCT00382733 - Completed - -
NCT01670175 Malignant Solid Tumor ... More >> Childhood Solid Tumor Less << Phase 1 Completed - United States, California ... More >> UCSF Benioff Children's Hospital San Francisco, California, United States, 94143 Less <<
NCT01690598 Ovarian Cancer Phase 1 Phase 2 Completed - Denmark ... More >> Department of Oncology, Vejle Hospital Vejle, Denmark, DK-7100 Less <<
NCT00158886 Carcinoma, Renal Cell Phase 1 Terminated - United States, Florida ... More >> GSK Investigational Site Tampa, Florida, United States, 33612-9497 Less <<
NCT00611468 Metastatic Solid Tumor Phase 1 Completed - United States, Tennessee ... More >> The West Clinic Memphis, Tennessee, United States, 38120 Less <<
NCT00611468 - Completed - -
NCT00257816 Cervical Cancer Phase 2 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT01003938 - Terminated(due to administrati... More >>ve issue and financial sponsor decision to suspend ovarian cancer studies) Less << - -
NCT01003938 Ovarian Cancer Phase 2 Terminated(due to administrati... More >>ve issue and financial sponsor decision to suspend ovarian cancer studies) Less << - United States, New York ... More >> Bellevue Hospital Center New York, New York, United States, 10016 NYU Clinical Cancer Center New York, New York, United States, 10016 Tisch Hospital New York, New York, United States, 10016 Less <<
NCT03193463 Glioma Early Phase 1 Recruiting December 2020 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Michael A. Vogelbaum, MD, PhD    216-444-8564    vogelbm@ccf.org    Principal Investigator: Michael A. Vogelbaum Less <<
NCT02569957 Malignant Ovarian Endometrioid... More >> Tumor Malignant Ovarian Serous Tumor Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 2 Terminated(The trial was halte... More >>d prematurely due to slow accrual.) Less << - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT02569957 - Terminated(The trial was halte... More >>d prematurely due to slow accrual.) Less << - -
NCT01600573 Ovarian Cancer Phase 1 Phase 2 Unknown March 2017 Germany ... More >> Charité Campus Virchow-Klinikum Recruiting Berlin, Germany, 13353 Contact: Jalid Sehouli, Prof. Dr.    +49 (0) 30 450 ext 564002    jalid.sehouli@charite.de    Contact: Radoslav Chekerov, Dr.    +49 (0) 30/450 ext 664399    radoslav.chekerov@charite.de    Principal Investigator: Jalid Sehouli, Prof. Dr.          Sub-Investigator: Radoslav Chekerov, Dr. Less <<
NCT01177501 Ovarian Cancer|Relapses PHASE1 TERMINATED 2025-03-12 Frédéric Selle, Paris, 75020, ... More >>France Less <<
NCT01736800 Central Nervous System (CNS) M... More >>etastases Brain Metastases Less << Phase 2 Withdrawn(No enrollment and PI... More >> requested study termination per IRB system.) Less << - United States, Texas ... More >> Houston Methodist Hospital Houston, Texas, United States, 77030 Methodist Neurological Institute - Department of Neurosurgery Houston, Texas, United States, 77030 Less <<
NCT01037023 Lung Cancer, Small Cell COMPLETED 2025-11-14 GSK Investigational Site, Seon... More >>gnam-si, Gyeonggi-do, 463-707, Korea, Republic of|GSK Investigational Site, Seoul, 137-701, Korea, Republic of Less <<
NCT02298348 Neuroblastoma Phase 1 Active, not recruiting May 2019 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Colorado Children Hospital of Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago, Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston, Massachusetts, United States, 02115 United States, Michigan C.S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Texas Cook Children's Healthcare System Fort Worth, Texas, United States, 76104 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT02500459 Brain Tumor H... More >>igh Grade Glioma Less << Early Phase 1 Recruiting December 2019 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Michael A Vogelbaum, MD, PhD    216-444-8564    vogelbm@ccf.org Less <<
NCT02278510 Malignant Glioma ... More >> WHO Grade III or IV Recurrent Glioma Less << Early Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT02649673 Small Cell Lung Cancer ... More >> Ovarian Cancer Less << Phase 1 Phase 2 Recruiting July 27, 2019 United States, Florida ... More >> Florida Cancer Specialists-Sarasota Recruiting Sarasota, Florida, United States, 34232 United States, Oklahoma Oklahoma University Health Science Center/Stephenson Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Less <<
NCT02963090 Small Cell Lung Cancer Phase 2 Active, not recruiting May 20, 2019 United States, Iowa ... More >> Des Moines Oncology Research Association Des Moines, Iowa, United States, 50309 Less <<
NCT02303028 Solid Tumors ... More >>Central Nervous System Tumors Less << Phase 1 Phase 2 Recruiting December 2018 Canada, Alberta ... More >> Alberta Children's Hospital Recruiting Calgary, Alberta, Canada Contact: Pina Giuliano          Principal Investigator: Victor Lewis          Canada, British Columbia BC Children's Hospital Recruiting Vancouver, British Columbia, Canada Contact: Stephanie Badour          Contact: Jessica Davis          Principal Investigator: Rebecca Deyell          Canada, Manitoba CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada Contact: Rebekah Hiebert          Contact: Kathy Hjalmarsson          Principal Investigator: John Doyle          Canada, Nova Scotia IWK Health Centre Recruiting Halifax, Nova Scotia, Canada Contact: Lynn Russell          Principal Investigator: Jason Berman          Canada, Ontario Children's Hospital of Eastern Ontario (CHEO) Recruiting Ottawa, Ontario, Canada Contact: Isabelle LaForest          Principal Investigator: Donna Johnston          The Hospital for Sick Children Recruiting Toronto, Ontario, Canada Contact: Gina Lee          Principal Investigator: Daniel Morgenstern          Canada, Quebec CHU St. Justine Hopital Recruiting Montreal, Quebec, Canada Contact: Dominique Lafreniere          Principal Investigator: Monia Marzouki Less <<
NCT00808899 Neuroblastoma Phase 2 Terminated(Voluntarily closed ... More >>and terminated by the PI due to lack of feasibility) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03059667 Small Cell Lung Cancer ... More >> Small Cell Lung Cancer Limited Stage Small Cell Lung Cancer Extensive Stage Less << Phase 2 Active, not recruiting December 2018 France ... More >> Annemasse - CH Ambilly, France, 74100 Angers - CHU Angers, France, 49000 CH Colmar, France CHRU Grenoble Grenoble, France Centre Hospitalier - Pneumologie Le Mans, France, 72000 Lorient - CHBS Lorient, France Montpellier - CHRU Montpellier, France, 34295 Mulhouse - CH Mulhouse, France, 68000 Centre Antoine Lacassagne Nice, France AP-HP Hopital Tenon - Pneumologie Paris, France, 75020 APHP - Paris Bichat Paris, France, 75877 GH Paris Saint-Joseph Paris, France CHG de Pau Pau, France HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Rouen - CHU Rouen, France, 76000 Centre Hospitalier Saint-Quentin, France Toulouse - CHU Larrey Toulouse, France CHU Tours - Pneumologie Tours, France Less <<
NCT00003733 Ovarian Cancer Phase 2 Unknown - United Kingdom ... More >> Charing Cross Hospital London, England, United Kingdom, W6 8RF Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Less <<
NCT00808899 - Terminated(Voluntarily closed ... More >>and terminated by the PI due to lack of feasibility) Less << - -
NCT02312245 Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 2 Recruiting June 2020 United States, Arizona ... More >> Mayo Clinic Recruiting Phoenix, Arizona, United States, 85054 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: John K. Camoriano          United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States, 32224 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Gerardo Colon-Otero          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Saravut J. Weroha Less <<
NCT01606878 Recurrent Childhood Anaplastic... More >> Large Cell Lymphoma Recurrent Neuroblastoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Active, not recruiting - -
NCT00327171 Neoplasms Can... More >>cer of the Ovary Less << Phase 2 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Australia Sanofi-Aventis Administrative Office Macquarie Park, Australia Canada Sanofi-Aventis Administrative Office Laval, Canada France Sanofi-Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milano, Italy Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Portugal Sanofi-Aventis Administrative Office Porto Salvo, Portugal Spain Sanofi-Aventis Administrative Office Barcelona, Spain Sweden Sanofi-Aventis Administrative Office Bromma, Sweden Switzerland Sanofi-Aventis Administrative Office Geneva, Switzerland Less <<
NCT03165292 Very High Risk Neuroblastoma Phase 2 Not yet recruiting June 2025 France ... More >> Gustave Roussy Not yet recruiting Villejuif, Val de Marne, France, 94805 Contact: Jonathan RUBINO    0142113891 ext +33    jonathan.rubino@gustaveroussy.fr    Contact: Camille JANNIN    0142114884 ext +33    camille.jannin@gustaveroussy.fr    Principal Investigator: Dominique VALTEAU COUANET, MD, PhD Less <<
NCT00005051 Ovarian Cancer Phase 2 Completed - United States, New York ... More >> Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 New York Hospital Medical Center of Queens Fresh Meadows, New York, United States, 11365 Saint Vincent Catholic Medical Center of New York New York, New York, United States, 10011 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 St. Luke's-Roosevelt Hospital Center - Roosevelt Division New York, New York, United States, 10019 New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 Mount Sinai Medical Center, NY New York, New York, United States, 10029 Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 New York Medical College Valhalla, New York, United States, 10595 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-3236 Less <<
NCT00314678 Epithelial Ovarian Cancer ... More >> Primary Peritoneal Cancer Less << Phase 2 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT01064466 Small Cell Lung Cancer Phase 3 Active, not recruiting August 2020 United States, Maryland ... More >> Medicine Invention Design Incorporation (MIDI) - IORG0007849 Bethesda, Maryland, United States, 20852 MIDI Clinical Trial Site Type 1 -c/o- Dr. Han Xu - Physicians assigned by CRO / IRB / IORG Bethesda, Maryland, United States, 20852 MIDI Clinical Trial Site Type 2 -c/o- Dr. Han Xu - Investigators assigned by CRO / IRB / IORG Bethesda, Maryland, United States, 20852 MIDI Clinical Trial Site Type 3 -c/o- Dr. Han Xu - Laboratories assigned by CRO / IRB / IORG Bethesda, Maryland, United States, 20852 Less <<
NCT00006032 Breast Cancer Phase 2 Terminated(low accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT00004137 Lung Cancer Phase 2 Completed - -
NCT03475121 Unilateral Retinoblastoma Phase 3 Recruiting December 31, 2025 Argentina ... More >> Hospital JP Garrahan Recruiting Buenos Aires, CF, Argentina, C1245AAL Contact: Carolina Cernadas, MD    541141226335    coordinacioninvestigacion@garrahan.gov.ar    Contact: Guillermo Chantada, MD, PhD    541141226000    gchantada@yahoo.com    Principal Investigator: Claudia Sampor, MD Less <<
NCT00327171 - Completed - -
NCT01783535 Retinoblastoma Phase 2 Recruiting June 2022 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Rachel C. Brennan, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Rachel C. Brennan, MD Less <<
NCT01857934 Neuroblastoma Phase 2 Recruiting July 2021 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Wayne L. Furman, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Wayne L. Furman, MD Less <<
NCT00003211 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Cancer Center Houston, Texas, United States, 77030-2399 Australia, New South Wales Children's Hospital at Westmead Westmead, New South Wales, Australia, 2145 Australia, Victoria Royal Children's Hospital Parkville, Victoria, Australia, 3052 Less <<
NCT00033696 Lung Cancer Phase 2 Completed - -
NCT02481830 Lung Cancer Phase 3 Active, not recruiting November 30, 2019 -
NCT00005026 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 1 Completed - -
NCT00877110 Neuroblastoma ... More >> Bone Marrow, Sympathetic Nervous System Less << Phase 1 Active, not recruiting April 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00003619 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic Syndromes Thrombocytopenia Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Medical College of Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19129 Medical College of Pennsylvania Philadelphia, Pennsylvania, United States, 19129 Less <<
NCT00003297 Ovarian Cancer Phase 1 Phase 2 Completed - United States, District of Col... More >>umbia Vincent T. Lombardi Cancer Research Center, Georgetown University Washington, District of Columbia, United States, 20007 Less <<
NCT01795430 Adult Supratentorial Primitive... More >> Neuroectodermal Tumor (PNET) Ewing Sarcoma of Bone Extraosseous Ewing Sarcoma Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Not Applicable Withdrawn(No participants enro... More >>lled.) Less << - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT02308527 Neuroblastoma Phase 2 Recruiting January 2022 Austria ... More >> St Anna Children's Hospital and CCRI/Studies and Statistics Recruiting Vienna, Austria, A-1090 Contact: Ruth Ladenstein, MD    43 1 40470 4750    ruth.ladenstein@ccri.at    Principal Investigator: Ruth Ladenstein, MD          Denmark University Hospital Rigshospitalet Recruiting Copenhagen, Denmark, DK-2100 Contact: Karsten Nysom, MD    45 35 45 08 09    Karsten.Nysom@regionh.dk    Principal Investigator: Karsten Nysom, MD          France Hopital des Enfants Recruiting Toulouse, France, 31059 Contact: Herve Rubie, MD    33 534 55 86 11    rubie.h@chu-toulouse.fr    Principal Investigator: Herve Rubie, MD          Ireland Our Ladys Children's Hospital Dublin Recruiting Dublin, Ireland, Dublin 12 Contact: Cormac Owens, MD    35 31 409 6659    cormac.owens@olchc.ie    Principal Investigator: Cormac Owens, MD          Italy Ospedale Pediatrico Bambino Gseu Recruiting Rome, Italy, 00165 Contact: Aurora Castellano, MD       aurora.castellano@opbg.net    Principal Investigator: Aurora Castellano, MD          Spain Instituto de Investigacion Sanitaria Recruiting Valencia, Spain, 46026 Contact: Victoria Castel, MD    34 963 862 758    castel_vic@gva.es    Principal Investigator: Victoria Castel, MD          Switzerland Swiss Paediatric Oncology Group Recruiting Bern, Switzerland, 3008 Contact: Nicolas Gerber    +41 (0)31 508 42 38    'nicolas.gerber@kispi.uzh.ch'    Contact: TuMy DiepLai    +41 (0)31 508 42 38    Tu-My.Diep@spog.ch    Principal Investigator: Nicolas Gerber`          United Kingdom The Royal Marsden NHS Foundation Trust and Institute of Cancer Research Recruiting Sutton, Surrey, United Kingdom, SM2 5PT Contact: Andrew DJ Pearson, MD          Contact: Lucas Moreno, MD          Principal Investigator: Andrew DJ Pearson, MD Less <<
NCT00550784 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 1 Completed - -
NCT01342237 Brain Tumors Phase 2 Unknown February 2014 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, ph.D    82 2 2072 3304    kanghj@snu.ac.kr    Contact: Hyery Kim, MD    82 2 2072 0177    taban@hanmail.net Less <<
NCT01418859 - Unknown December 2015 China, Shanxi ... More >> Xi'an Jiaotong University College of Medicine Recruiting Xi'an, Shanxi, China, 710061 Contact: Zi Liu, M.D    086-18991232167    18991232167@189.cn    Contact: Tao Wang, M.D    086-18991232386    18991232386@189.cn    Sub-Investigator: Tao Wang, M.D Less <<
NCT00518193 Cervix Cancer Phase 2 Terminated(high rate of medull... More >>ar aplasia with infectious troubles.) Less << - France ... More >> CRLC Val d'Aurelle Montpellier, France, 34298 Hôpital HOTEL DIEU Paris, France, 75004 Oncologie, Hôtel-Dieu, 1 place du parvis Notre-Dame Paris, France, 75004 Centre Claudius Régaud Toulouse, France, 31052 Less <<
NCT01684878 - Completed - -
NCT00003812 Lung Cancer Phase 2 Completed - -
NCT00186888 - Active, not recruiting - -
NCT00186888 Retinoblastoma ... More >> Retinal Neoplasm Less << Phase 3 Active, not recruiting September 2021 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00006374 Lung Cancer Phase 2 Withdrawn(Slow accrual) - -
NCT02101788 Low Grade Ovarian Serous Adeno... More >>carcinoma Micropapillary Serous Carcinoma Ovarian Serous Adenocarcinoma Primary Peritoneal Serous Adenocarcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 2 Phase 3 Active, not recruiting - -
NCT00486564 Neuroblastoma Phase 1 Completed - United States, Missouri ... More >> St. Louis University/Cardinal Glennon Childrens Medical Center St. Louis, Missouri, United States, 63104 United States, Vermont University of Vermont/Vermont Children's Hospital Burlington, Vermont, United States, 05401 Less <<
NCT00130858 Sarcoma, Soft Tissue Phase 2 Completed - Germany ... More >> HELIOS Klinikum Erfurt GmbH Erfurt, Sachsen, Germany, 99089 Zentralklinikum Augsburg, Germany, 86156 Klinikum Berlin-Buch Berlin, Germany, 13125 Virchow Klinik Berlin, Germany, 13353 Zentrum für Kinderheilkunde Bonn, Germany, 53113 Zentralkrankenhaus Bremen Bremen, Germany, 28205 Universitätsklinik der technischen Universität Dresden Dresden, Germany, 01307 Heinrich-Heine-Universität Düsseldorf, Germany, 40001 Universitätsklinik für Kinderund Jugendliche Erlangen, Germany, 91054 Universitätsklinikum Essen Essen, Germany, 45147 Klinikum der Universität Frankfurt, Germany, 60590 Universitäts-Kinderklinik Freiburg Freiburg, Germany, 79106 Klinikum der Justus-Liebig-Universität Gießen, Germany, 35392 Georg-August-Universität Göttingen, Germany, 37075 Universitäts-Kinderklinik Hamburg Hamburg, Germany, 20251 Kinderklinik der Medizinischen Hochschule Hannover, Germany, 30625 Universitäts-Kinderklinik Heidelberg, Germany, 69112 Universitäts-Kinderklinik Homburg/saar, Germany, 66421 Klinik für Kinder- und Jugendmedizin Jena, Germany, 07740 Städtisches Klinikum Karlruhe Karlsruhe, Germany, 76131 Klinikum der Universität Kiel Kiel, Germany, 24105 Klinikum der Stadt Köln Köln, Germany, 50735 Universitäts-Kinderklinik Köln, Germany, 50931 Universitätsklinik und Poliklinik Leipzig, Germany, 04137 Kinderklinik St. Annastift Ludwigshafen, Germany, 67067 Medizinische Universität zu Lübeck Lübeck, Germany, 25538 Medizinische Fakultät Magdeburg, Germany, 39120 Klinikum der Johannes-Gutenberg-Universität Mainz, Germany, 55101 Dr. von Haunersches Kinderspital München, Germany, 80337 Städtisches Krankenhaus Technische Universität Schwabing München, Germany, 80804 Westfälische Wilhelms-Universität Münster, Germany, 48149 Cnopf'sche Kinderklinik Nürnberg, Germany, 90419 Klinik St. Hedwig Regensburg, Germany, 93049 Johanniter-Kinderklinik St.Augustin, Germany, 53757 Olgahospital Stuttgart, Germany, 70176 Universitäts-Kinderklinik Tübingen, Germany, 72076 Universitäts-Kinderklinik Ulm, Germany, 89075 Universitäts-Kinderklinik Würzburg, Germany, 97080 Less <<
NCT03042429 Neuroblastoma Phase 3 Completed - Germany ... More >> University of Cologne Koln, Germany, 50924 Less <<
NCT01684878 Ovarian Cancer Phase 3 Completed - -
NCT03763123 Ovarian Cancer Phase 1 Recruiting December 31, 2020 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China Contact: zheng hong    010-88196102    zhhong306@hotmail.com    Principal Investigator: zheng hong          Cancer Hospital Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China Contact: Wu Lingying    010-87788787    wulingying@csco.org.cn    Principal Investigator: wu lingying          China, Guangdong The first affiliated hospital,sun yat-sen university Recruiting Guangzhou, Guangdong, China Contact: Yao Shuzhong    020-87755766 ext 8185    yszlfy@163.com    Contact: Yao Shuzhong    02087755766 ext 02087755766    yszlfy@163.com    Principal Investigator: Yao Shuzhong          China, Hei Longjiang the Affiliated Cancer Hospital of Harbin Medical University Suspended Harbin, Hei Longjiang, China China, Hunan Hunan Cancer Hospital Recruiting Changsha, Hunan, China Contact: Zhang Keqiang    0731-89762695 ext 073189762695    1465217100@qq.com    Contact: Zhang Keqiang    073189762695 ext 073189762695    1465217100@qq.com    Principal Investigator: Zhang Keqiang          Wuhan Union Hospital Recruiting Wuhan, Hunan, China Contact: Li Guiling    027-83691785    lgl6714@163.com    Principal Investigator: Li Guiling Less <<
NCT03107988 Neuroblastoma Phase 1 Recruiting December 2020 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027-0700 Contact: Araz Marachelian, MD    323-361-5687    amarachelian@chla.usc.edu    UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94143 Contact: Katherine K. Matthay, MD    415-476-3831    matthayK@peds.ucsf.edu    United States, Colorado Children Hospital of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Margaret Macy, MD    720-777-8856    Margaret.macy@childrenscolorado.org    United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Kelly Goldsmith, MD    404-785-0853    kgoldsmith@emory.edu    United States, Illinois University of Chicago, Comer Children's Hospital Recruiting Chicago, Illinois, United States, 60637 Contact: Ami Desai, MD    773-843-3943    adesai12@peds.bsd.uchicago.edu    United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Recruiting Boston, Massachusetts, United States, 02115 Contact: Suzanne Shusterman, MD    617-632-3725    suzanne_shusterman@dfci.harvard.edu    United States, Michigan C.S Mott Children's Hospital Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Rajen Mody, MD       rmody@umich.edu    United States, North Carolina University of North Carolina Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Patrick Thompson, MD       patom@email.unc.edu    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229-3039 Contact: Brian Weiss, MD    513-636-9866    brian.weiss@chmcc.org    United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104-4318 Contact: Yael Mosse, MD    215-590-0965    mosse@chop.edu    United States, Texas Cook Children's Healthcare System Recruiting Fort Worth, Texas, United States, 76104 Contact: Meaghan Granger, MD    682-885-4007    mgranger@cookchildrens.org    United States, Washington Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle, Washington, United States, 98105 Contact: Navin Pinto, MD    206-987-5783    navin.pinto@seattlechildrens.org    Canada, Ontario Hospital for Sick Children Not yet recruiting Toronto, Ontario, Canada, M5G 1X8 Contact: Meredith Irwin, MD    416-813-7654    meredith.irwin@sickkids.ca    France Institut Curie Not yet recruiting Paris, Cedex, France, 05 Contact: Gudrun Schleiermacher, MD    144324550    gudrun.schleiermacher@curie.fr    United Kingdom Royal Marsden Hospital Not yet recruiting Sutton, Surrey, United Kingdom, SM25NG Contact: Louis Chelser, MD    2087224204    Louis.Chesler@icr.ac.uk Less <<
NCT00028743 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 Lions Gate Hospital North Vancouver, British Columbia, Canada, V7L 2L7 BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada, E1C 6Z8 Atlantic Health Sciences Corporation Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Dr. H. Bliss Murphy Cancer Centre St. John's, Newfoundland and Labrador, Canada, AIB 3V6 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Grand River Regional Cancer Centre Kitchener, Ontario, Canada, N2G 1G3 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Ottawa Health Research Institute - General Division Ottawa, Ontario, Canada, K1H 8L6 Niagara Health System St. Catharines, Ontario, Canada, L2R 7C6 Northeast Cancer Center Health Sciences Sudbury, Ontario, Canada, P3E 5J1 Thunder Bay Regional Health Science Centre Thunder Bay, Ontario, Canada, P7B 6V4 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Prince Edward Island PEI Cancer Treatment Centre,Queen Elizabeth Hospital Charlottetown, Prince Edward Island, Canada, C1A 8T5 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 Hopital du Sacre-Coeur de Montreal Montreal, Quebec, Canada, H4J 1C5 CHUQ-Pavillon Hotel-Dieu de Quebec Quebec City, Quebec, Canada, G1R 2J6 Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT03348670 Small Cell Lung Cancer Phase 3 Active, not recruiting May 28, 2020 United States, Maryland ... More >> Medicine Invention Design, Inc. (MIDI) - c/o - MIDINC Clinical Investigator Working Site North Bethesda, Maryland, United States, 20852 Less <<
NCT00028925 Lung Cancer Phase 2 Completed - -
NCT00186849 Neuroblastoma Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00003945 Cervical Cancer Phase 3 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Iowa John Stoddard Cancer Center at Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Mercy Cancer Center at Mercy Medical Center-Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316-2301 United States, Nebraska Midlands Cancer Center at Midlands Community Hospital Papillion, Nebraska, United States, 68128-4157 United States, New Mexico MBCCOP - University of New Mexico HSC Albuquerque, New Mexico, United States, 87131 United States, Pennsylvania Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 United States, Wisconsin CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay, Wisconsin, United States, 54307-3453 Australia, New South Wales Westmead Hospital Westmead, New South Wales, Australia, 2145 Peru Instituto de Enfermedades Neoplasicas Lima, Peru, 34 Puerto Rico San Juan City Hospital San Juan, Puerto Rico, 00936-7344 Less <<
NCT01696032 Ovarian Cancer Phase 2 Completed - -
NCT00997061 - Completed - -
NCT00005021 Lymphoma Smal... More >>l Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00601003 Neuroblastoma ... More >> Medulloblastoma Less << Phase 2 Recruiting December 2020 United States, California ... More >> Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: Mehrzad Milburn    858-966-8155       Principal Investigator: William Roberts, MD          United States, Connecticut Connecticut Children's Hospital Recruiting Hartford, Connecticut, United States, 06106 Contact: Sharon Huie-White    860-545-9337    shuie@connecticutchildrens.org    Principal Investigator: Michael Isakoff, MD          United States, Florida Arnold Palmer Hospital for Children- MD Anderson Recruiting Orlando, Florida, United States, 32806 Contact: Michelle Pope, RN    321-841-8588       Principal Investigator: Don Eslin, MD          United States, Hawaii Kapiolani Medical Center for Women and Children Recruiting Honolulu, Hawaii, United States, 96813 Contact: Andrea Siu, MPH    808-535-7169    andrea.siu@kapiolani.org    Principal Investigator: Randal Wada, MD          United States, Massachusetts Tufts Medical Center Recruiting Boston, Massachusetts, United States, 02111 Contact: Jennifer Truong    617-636-8885    jtruong@tuftsmedicalcenter.org    Principal Investigator: Michael Kelly, MD          United States, Michigan Helen DeVos Children's Hospital Recruiting Grand Rapids, Michigan, United States, 49503 Contact: Shannon MacKeigan    616-267-1162    shannon.mackeigan@helendevoschildrens.org    Principal Investigator: Deanna Mitchell, MD          Principal Investigator: Giselle Sholler, MD          United States, Minnesota Children's Hospital and Clinics on Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Courtney Haller    612-813-5913    courtney.haller@childrensmn.org    Principal Investigator: Jawhar Rawwas, MD          United States, Missouri Children's Mercy Hospitals and Clinics Recruiting Kansas City, Missouri, United States, 64108 Contact: Sara Soliman, RN    816-855-1977    sjsoliman@cmh.edu    Principal Investigator: Kathleen Neville, MD          Cardinal Glennon Children's Medical Center Recruiting Saint Louis, Missouri, United States, 63104 Contact: Katherine Maxwell, RN    314-268-4000       Principal Investigator: William Ferguson, MD          United States, North Carolina Levine Children's Hospital Recruiting Charlotte, North Carolina, United States, 28204 Contact: Elizabeth Arroyo-Green    980-442-2312    Elizabeth.ArroyoGreen@carolinashealthcare.org    Principal Investigator: Javier Oesterheld, MD          United States, Pennsylvania Penn State Milton S. Hershey Medical Center and Children's Hospital Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Suzanne Treadway       streadway@hmc.psu.edu    Principal Investigator: Valerie Brown, MD          United States, South Carolina Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Jacqueline Kraveka, MD    843-792-2957       Principal Investigator: Jaqueline Kraveka, MD          United States, Texas Children's Medical Center Recruiting Dallas, Texas, United States, 75235 Contact: Michelle Rivas    214-456-0004    michelle.rivas@childrens.com    Principal Investigator: Ted Laetsch, MD          Texas Children's Cancer and Hematology Centers Recruiting Houston, Texas, United States, 77030 Contact: Peter Zage, MD    832-824-4615    pezage@txch.org    Principal Investigator: Peter Zage, MD, PhD          United States, Utah Primary Children's Hospital Recruiting Salt Lake City, Utah, United States, 84113 Contact: Lisa Smith    801-662-4710    Lisa.Smith@imail.org    Principal Investigator: Mark Fluchel, MD Less <<
NCT00064077 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma Recurrent Cervical Carcinoma Stage IVB Cervical Cancer Less << Phase 3 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00003958 Adult Malignant Mesenchymoma ... More >> Adult Rhabdomyosarcoma Alveolar Childhood Rhabdomyosarcoma Childhood Malignant Mesenchymoma Embryonal Childhood Rhabdomyosarcoma Embryonal-botryoid Childhood Rhabdomyosarcoma Nonmetastatic Childhood Soft Tissue Sarcoma Previously Untreated Childhood Rhabdomyosarcoma Stage I Adult Soft Tissue Sarcoma Stage II Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00003827 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Unknown - United States, California ... More >> Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States, 91010-3000 Less <<
NCT00064077 - Completed - -
NCT00003331 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous Condition Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Kaplan Cancer Center New York, New York, United States, 10016 Less <<
NCT00462787 Leukemia Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00002814 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT02107378 Epithelial Ovarian Carcinoma Phase 2 Terminated(sponsor decision) - Czech Republic ... More >> Brno, Czech Republic, 625 00 Nový Jičín, Czech Republic, 741 01 Olomouc, Czech Republic, 775 20 Ostrava, Czech Republic, 708 52 Prague, Czech Republic, 150 06 Germany Cologne, Germany, 50931 Dresden, Germany, 01307 Erlangen, Germany, 91054 Poland Bialystok, Poland, 15-276 Krakow, Poland, 31-501 Lublin, Poland, 20-081 Poznan, Poland, 60-569 Less <<
NCT00006012 Drug/Agent Toxicity by Tissue/... More >>Organ Lung Cancer Radiation Toxicity Less << Phase 1 Phase 2 Completed - -
NCT00002693 Leukemia Neut... More >>ropenia Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00043927 Small Cell Lung Cancer Phase 3 Completed - -
NCT00006373 Lymphoma Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT00100477 Non-Hodgkin's Lymphoma ... More >> Leukemia Less << Phase 2 Completed - United States, Florida ... More >> North Florida/South Georgia Veterans Health System Gainesville, Florida, United States, 32608 Less <<
NCT01143779 Advanced Cancer Phase 1 Active, not recruiting June 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00003732 Ovarian Cancer Phase 2 Completed - Denmark ... More >> Rigshospitalet - Copenhagen University Hospital Copenhagen, Denmark, 2100 Less <<
NCT00025272 Lung Cancer Phase 2 Completed - United States, North Carolina ... More >> Southeastern Medical Oncology Center Goldsboro, North Carolina, United States, 27534-9479 Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1082 United States, South Carolina CCOP - Greenville Greenville, South Carolina, United States, 29615 CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 United States, Virginia MBCCOP - Massey Cancer Center Richmond, Virginia, United States, 23298-0037 Less <<
NCT00634244 - Completed - -
NCT00057837 Extensive Stage Small Cell Lun... More >>g Cancer Less << Phase 2 Completed - -
NCT00041015 Lung Cancer Phase 3 Completed - United States, Ohio ... More >> Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00002986 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Tennessee Saint Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-2794 Less <<
NCT00057720 Ovarian Neoplasms Phase 3 Completed - -
NCT00004186 Lung Cancer Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 Less <<
NCT00043862 Lung Cancer, Small Cell ... More >> Small Cell Lung Cancer Less << Phase 2 Completed - -
NCT00250094 Ovarian Cancer Phase 1 Completed - United States, New Mexico ... More >> University of New Mexico Albuquerque, New Mexico, United States, 87131 Less <<
NCT00113789 Ovarian Cancer Phase 2 Completed - -
NCT00038545 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00057837 - Completed - -
NCT00006199 Cancer Phase 1 Unknown - United States, New York ... More >> NYU Cancer Institute Recruiting New York, New York, United States, 10016 Contact: Anita Tierney    212-263-2173 Less <<
NCT01231906 Non-Metastatic Extraskeletal E... More >>wing Sarcoma Peripheral Primitive Neuroectodermal Tumor of Bone Peripheral Primitive Neuroectodermal Tumor of Soft Tissues Less << Phase 3 Active, not recruiting - -
NCT00005792 Multiple Myeloma ... More >> Plasma Cell Neoplasm Less << Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT00634244 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Arizona Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa Siouxland Hematology Oncology Associates Sioux City, Iowa, United States, 51101 United States, Maryland Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Ohio The Jewish Hospital Cincinnati, Ohio, United States, 45236 United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States, 17822-2001 Geisinger Medical Center-Cancer Center Hazleton Hazleton, Pennsylvania, United States, 18201 Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Lewistown Hospital Lewistown, Pennsylvania, United States, 17044 Geisinger Medical Group State College, Pennsylvania, United States, 16801 Mount Nittany Medical Center State College, Pennsylvania, United States, 16803 Geisinger Wyoming Valley Wilkes-Barre, Pennsylvania, United States, 18711 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Israel Rambam Medical Center Haifa, Israel, 31096 Less <<
NCT00389766 Neuroblastoma Phase 2 Withdrawn(Withdrawn because pr... More >>otocol has been discontinued. It was never opened.) Less << - -
NCT00488709 Acute Myeloid Leukemia Phase 4 Completed - Spain ... More >> Hospital Juan Canalejo A Coruña, Spain Hospital Ntra. Sra. de Sonsoles Avila, Spain Hospital germans Trias i Pujol Badalona, Spain Centro Médico Teknon Barcelona, Spain Hospital Sant Pau Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital General Yagüe Burgos, Spain Hospital de Jerez Cadiz, Spain Complejo hospitalario Xeral-Calde Lugo, Spain Hospital Clínico Universitario San Carlos Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Virgen de la Victoria Málaga, Spain Hosptal Joan XXIII Tarragona, Spain Hospital Verge de la Cinta Tortosa, Spain Hospital Rio Hortega Valladolid, Spain Hospital Clinico Lozano Blesa Zaragoza, Spain Less <<
NCT00002588 Leukemia Phase 1 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT03098030 Small Cell Lung Cancer Phase 2 Phase 3 Active, not recruiting November 2019 -
NCT00437073 Neoplasms, Breast Phase 2 Terminated(Lapatinib-topotecan... More >> arm enrollment closed early per protocol amendment 2. Then enrollment into remaining arm terminated due to operational issues.) Less << - -
NCT00046800 Ovarian Neoplasms Phase 2 Completed - United States, New York ... More >> NYU- Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 United States, Tennessee The Sarah Cannon Cancer Center, Centennial Medical Center Nashville, Tennessee, United States, 37203 United Kingdom St Chad's Unit Birmingham, United Kingdom, B18 7QH Beatson Oncology Centre Glasgow, United Kingdom, G11 6NT Royal Surrey County Hospital Guildford, Surrey, United Kingdom, GU2 7XX Royal Marsden NHS Trust London, United Kingdom, SW3 6JJ Northern Centre for Cancer Research, Newcastle General Hospital Newcastle-upon-Tyne, United Kingdom, NE4 6BE Mount Vernon Hospital Northwood, Middlesex, United Kingdom, HA6 2RN CRC Department of Medical Oncology Sutton Surrey, United Kingdom, SM2 5PT Taunton & Somerset Hospital Taunton, United Kingdom, TA1 5DA Medical Oncology Unit, Torbay District General Hospital Torquay, United Kingdom, TQ2 7AA Less <<
NCT00437073 - Terminated(Lapatinib-topotecan... More >> arm enrollment closed early per protocol amendment 2. Then enrollment into remaining arm terminated due to operational issues.) Less << - -
NCT00638898 Solid Tumor A... More >>dult Central Nervous System Germ Cell Tumor Adult Rhabdomyosarcoma Childhood Central Nervous System Germ Cell Tumor Childhood Soft Tissue Sarcoma Ewing Sarcoma Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Ovarian Mixed Germ Cell Tumor Previously Untreated Childhood Rhabdomyosarcoma Recurrent Adult Brain Tumor Recurrent Adult Soft Tissue Sarcoma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Malignant Germ Cell Tumor Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Recurrent Childhood Visual Pathway Glioma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Extragonadal Germ Cell Tumor Recurrent Extragonadal Non-seminomatous Germ Cell Tumor Recurrent Malignant Testicular Germ Cell Tumor Recurrent Neuroblastoma Recurrent Ovarian Germ Cell Tumor Recurrent Wilms Tumor and Other Childhood Kidney Tumors Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Active, not recruiting June 2019 United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less <<
NCT00053287 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00002948 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Terminated - United States, Connecticut ... More >> Yale Comprehensive Cancer Center New Haven, Connecticut, United States, 06520-8032 Less <<
NCT00316173 Ovarian Cancer ... More >> Neoplasms, Ovarian Less << Phase 2 Completed - -
NCT00003382 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 1 Terminated - United States, California ... More >> Community Hospital of Los Gatos Los Gatos, California, United States, 95032 Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Women's Cancer Center Palo Alto, California, United States, 94304 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Iowa Holden Comprehensive Cancer Center at The University of Iowa Iowa City, Iowa, United States, 52242-1009 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00316173 - Completed - -
NCT00334867 Sarcoma Phase 3 Withdrawn(withdrawn) - -
NCT00003065 Cervical Cancer Phase 2 Completed - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 Less <<
NCT03088813 Small Cell Lung Cancer Phase 2 Phase 3 Recruiting December 2022 -
NCT00006454 Fallopian Tube Cancer ... More >> Ovarian Cancer Less << Phase 3 Completed - Germany ... More >> Universitaetsklinikum Charite Berlin, Germany, D-10117 Universitaetskliniken Bonn Bonn, Germany, D-53105 Zentralkrankenhaus Bremen, Germany, D-28205 Medizinische Klinik I Dresden, Germany, D-01307 Universitaetsklinik Duesseldorf Duesseldorf, Germany, D-40225 Evangelisches Krankenhaus Dusseldorf, Germany, DOH-4-0217 Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Stadtische Kliniken Frankfurt-Hochst Frankfurt, Germany, DOH-6-5929 Universitaetsklinik Goettingen Gottingen, Germany, D-37075 Klinik Fuer Innere Medizin Hematology/Oncology, Ernst Moritz Armdt Universitaet Greifswald, Germany, D-17487 Frauenklinik der MHH Hannover, Germany, 30659 Vincentius Krankenhaus Karlsruhe, Germany, D-76137 Christian-Albrechts University of Kiel Kiel, Germany, D-24105 Klinik der Otto-v.-Guericke-Universitat Magdeburg, Germany, 39108 Klinik und Poliklinik fuer Kinderheilkunde Muenster, Germany, D-48129 Klinikum Grosshadern Munich, Germany, D-81377 Klinikum Rechts Der Isar/Technische Universitaet Muenchen Munich, Germany, D-81675 Universitaetsklinikum Tuebingen Tuebingen, Germany, D-72076 Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, D-65199 Less <<
NCT00189566 Ovarian Cancer ... More >> Fallopian Tube Cancer Malignant Tumor of Peritoneum Less << Phase 2 Completed - France ... More >> Hôpital Hotel Dieu Paris, France, 75004 Less <<
NCT00097019 Ovarian Cancer Phase 2 Completed - -
NCT00276796 Cervical Cancer Phase 2 Completed - -
NCT00054444 Cervical Adenocarcinoma ... More >> Cervical Squamous Cell Carcinoma Stage IB Cervical Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage III Cervical Cancer Stage IVA Cervical Cancer Less << Phase 1 Completed - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Missouri University of Missouri - Ellis Fischel Columbia, Missouri, United States, 65212 United States, New Jersey Cooper Hospital University Medical Center Camden, New Jersey, United States, 08103 United States, Ohio MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Riverside Methodist Hospital Columbus, Ohio, United States, 43214 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Cancer Care Associates-Midtown Tulsa, Oklahoma, United States, 74104 Tulsa Cancer Institute Tulsa, Oklahoma, United States, 74146 Less <<
NCT00193297 Ovary Cancer Phase 2 Completed - -
NCT00006125 Lymphoma Phase 2 Completed - -
NCT00003745 Sarcoma Phase 2 Completed - -
NCT00084565 Prostate Cancer Phase 2 Withdrawn(Study was never acti... More >>vated at Fox Chase Cancer Center.) Less << - -
NCT00826891 Cervical Cancer Phase 2 Unknown January 2010 -
NCT00070200 Neuroblastoma Phase 1 Completed - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0106 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Mary Bridge Children's Hospital and Health Center - Tacoma Tacoma, Washington, United States, 98405 Australia, New South Wales Westmead Hospital Westmead, New South Wales, Australia, 2145 Less <<
NCT03541928 High-risk Prostate Cancer ... More >> Prostate Cancer Less << Phase 2 Recruiting July 2023 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Edward B Butler Less <<
NCT01107665 Stage III Melanoma ... More >> Stage IV Melanoma Unresectable Melanoma Less << Phase 2 Active, not recruiting January 2019 United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT02267213 Hepatocellular Carcinoma Phase 2 Completed - China ... More >> 307 Hospital of PLA Beijin, China, 100071 Nanjing Bayi Hospital Nanjing, China, 210002 Shanghai Cancer Hospital, Fudan University Shanghai, China, 200032 Zhongshan Hospital, Fudan University Shanghai, China, 200032 Taiwan Chiayi Chang Gung Memorial Hosipital Chiayi City, Taiwan Kaohsiung Chang Gung Memorial Hospital Kaohsiung, Taiwan China Medical University Hosipital Taichung, Taiwan National Cheng Kung University Hospital Tainan, Taiwan Mackay Memorial Hosipital Taipei City, Taiwan National Taiwan University Hosipital Taipei, Taiwan Taipei Veterans General Hospital Taipei, Taiwan LinKou Chang Gung Memorial Hosipital Taoyuan, Taiwan Less <<
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT01576692 Neuroblastoma Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03057626 - Recruiting August 1, 2020 -
NCT03651206 Ovarian Carcinosarcoma ... More >> Endometrial Carcinosarcoma Less << Phase 2 Phase 3 Not yet recruiting January 2023 -
NCT00002643 Neutropenia S... More >>arcoma Less << Phase 2 Completed - -
NCT00040872 Neuroblastoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00379457 Sarcoma Phase 3 Unknown - Austria ... More >> St. Anna Children's Hospital Recruiting Vienna, Austria, A-1090 Contact: Ruth Ladenstein, MD    43-1-404-700       Belgium Hopital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Christine Devalck, MD    32-2-477-2678       Denmark Rigshospitalet - Copenhagen University Hospital Recruiting Copenhagen, Denmark, 2100 Contact: Catherine Rechnitzer, MD, PhD    45-3545-1368    rechnitzer@rh.dk    Ireland Our Lady's Hospital for Sick Children Crumlin Recruiting Dublin, Ireland, 12 Contact: Fin Breatnach, MD, FRCPE    353-1-409-6659    fin.breatnach@olhsc.ie    Spain Vall d'Hebron University Hospital Recruiting Barcelona, Spain, 08035 Contact: Soledad Gallego, MD, PhD    34-93-489-3090    sgallego@vhebron.net    Sweden Uppsala University Hospital Recruiting Uppsala, Sweden, SE-75185 Contact: Gustaf Ljungman, MD    46-18-611-5586       Switzerland University Children's Hospital Recruiting Zurich, Switzerland, CH-8032 Contact: Felix Niggli, MD    41-44-266-7823       United Kingdom Birmingham Children's Hospital Recruiting Birmingham, England, United Kingdom, B16 8ET Contact: David Hobin, MD    44-121-454-4851       Institute of Child Health at University of Bristol Recruiting Bristol, England, United Kingdom, BS2 8AE Contact: M. C. G. Stevens, MD    44-117-342-0205    m.stevens@bristol.ac.uk    Addenbrooke's Hospital Recruiting Cambridge, England, United Kingdom, CB2 2QQ Contact: Denise Williams, MD    44-1223-256-298       Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Martin Elliott, MD    44-113-206-4988       Leicester Royal Infirmary Recruiting Leicester, England, United Kingdom, LE1 5WW Contact: Johann Visser, MD    44-116-258-5309    johannes.visser@uhl-tr.nhs.uk    Royal Liverpool Children's Hospital, Alder Hey Recruiting Liverpool, England, United Kingdom, L12 2AP Contact: Heather P. McDowell, MD    44-151-293-3679       Middlesex Hospital Recruiting London, England, United Kingdom, W1T 3AA Contact: Ananth Shankar, MD    44-20-7380-9300 ext. 9950       Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Julia Chisholm, MD    44-20-7829-7924       Royal Manchester Children's Hospital Recruiting Manchester, England, United Kingdom, M27 4HA Contact: Bernadette Brennan, MD    44-161-922-2227    bernadette.brennan@cmmc.nhs.uk    Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Juliet Hale, MD    44-191-282-4101    j.p.hale@ncl.ac.uk    Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Martin Hewitt, MD, BSc, FRCP, FRCPCH    44-115-924-9924 ext. 63394    martin.hewitt@nuh.nhs.uk    Oxford Radcliffe Hospital Recruiting Oxford, England, United Kingdom, 0X3 9DU Contact: Sheila Lane, MD    44-1865-234-205       Children's Hospital - Sheffield Recruiting Sheffield, England, United Kingdom, S10 2TH Contact: Mary P. Gerrard, MBChB, FRCP, FRCPCH    44-114-271-7366    mary.gerrard@sch.nhs.uk    Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Janice A. Kohler, MD, FRCP    44-23-8079-6942       Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Kathy Pritchard-Jones, MD    44-20-8661-3452 ext 3498       Royal Belfast Hospital for Sick Children Recruiting Belfast, Northern Ireland, United Kingdom, BT12 6BE Contact: Anthony McCarthy, MD    44-289-063-3631    anthonymcarthy@royalhospital.n.i.nhs.uk    Royal Aberdeen Children's Hospital Recruiting Aberdeen, Scotland, United Kingdom, AB25 2ZG Contact: Derek King, MD    44-1224-681-818       Royal Hospital for Sick Children Recruiting Edinburgh, Scotland, United Kingdom, EH9 1LF Contact: W. Hamish Wallace, MD    44-131-536-0426       Royal Hospital for Sick Children Recruiting Glasgow, Scotland, United Kingdom, G3 8SJ Contact: Milind D. Ronghe, MD    44-141-201-9309       Childrens Hospital for Wales Recruiting Cardiff, Wales, United Kingdom, CF14 4XW Contact: Meriel Jenney, MD    44-292-074-2107 Less <<
NCT00004006 Retinoblastoma Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-2794 Less <<
NCT01703910 Adenocarcinoma of Colon ... More >> Adenocarcinoma of Rectum Metastatic Disease Less << Phase 2 Completed - Spain ... More >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 Less <<
NCT00410631 Neuroblastoma Phase 3 Unknown - -
NCT00187083 Acute Lymphoblastic Leukemia Phase 3 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00003064 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 1 Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Less <<
NCT03699449 Platinum-resistant Recurrent O... More >>varian Cancer Less << Phase 2 Recruiting September 2022 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Jae-Woen Kim, MD, Ph.D    +82-2-2072-3511    kjwksh@snu.ac.kr    Principal Investigator: Jae-Woen Kim, MD, Ph.D          Yonsei University Health System, Severance Hospital Recruiting Seoul, Korea, Republic of, 03722 Contact: Jung-Yun Lee    82-2-2228-2230    jungyunlee@yuhs.ac    Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: Byoung-Gie Kim, MD, Ph.D    82-2-3410-3513    bgkim@skku.edu    Principal Investigator: Byoung-Gie Kim, MD, Ph.D Less <<
NCT01175356 Disseminated Neuroblastoma ... More >> Ganglioneuroblastoma Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Regional Neuroblastoma Stage 4S Neuroblastoma Less << Not Applicable Completed - -
NCT00526318 Neuroblastoma Not Applicable Unknown - -
NCT01175356 - Completed - -
NCT02665065 Acute Myeloid Leukemia ... More >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Less << Phase 3 Recruiting June 2020 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Less <<
NCT02282020 Relapsed Ovarian Cancer, BRCA ... More >>Mutation, Platinum Sensitivity Less << Phase 3 Active, not recruiting January 1, 2021 -
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT03126916 Childhood Ganglioneuroblastoma... More >> Childhood Neuroblastoma INRG Stage L2 INRG Stage M INRG Stage MS NMYC Gene Amplification Recurrent Neuroblastoma Less << Phase 3 Recruiting June 30, 2026 -
NCT00747474 Advanced Solid Tumors Phase 1 Completed - United States, Georgia ... More >> Medical College of Georgia Augusta, Georgia, United States, 30912 United States, Massachusetts Bidmc, Dfci, Mgh Boston, Massachusetts, United States, 02215 United States, New York Montefiore Medical Center Bronx, New York, United States, 10461 Taiwan National Taiwan University Hospital Taipei, Taiwan Less <<
NCT03236857 Malignancies ... More >>Acute Lymphoblastic Leukemia (ALL) Acute Myeloid Leukemia (AML) Non-Hodgkin's Lymphoma Neuroblastoma Less << Phase 1 Recruiting April 7, 2022 -
NCT00747474 - Completed - -
NCT00793351 Neuroblastoma Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02339753 Pediatric Solid Tumor Phase 2 Unknown December 2016 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Principal Investigator: HeeYeong shin Less <<
NCT02786719 Neuroblastoma Not Applicable Recruiting June 2019 United States, California ... More >> Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: Laura Conner    858-966-5983    LConner@rchsd.org    Principal Investigator: Peter Zage, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Sarah Whittle, MD, BA    832-822-4242    sbwhittl@txch.org Less <<
NCT03071848 - Completed - Argentina ... More >> Hospital General de Agudos J. A. Penna ; Breast Pathology Buenos Aires, Argentina, 1437 Instituto Ángel H. Roffo - Universidad de Buenos Aires Buenos Aires, Argentina, B1650 Hospital Julio C. Perrando Chaco, Argentina Hospital General de Agudos Juan Antonio Fernandez Ciudad Autonoma de Buenos Aires, Argentina, 1425 Hospital Pablo Soria Jujuy, Argentina Centro Oncologico Riojano Integral (CORI) La Rioja, Argentina, F5300COE Hospital Interzonal General De Agudos "Luisa C. de Gandulfo" Lomas de Zamora, Argentina Hospital Privado de Comunidad; Oncology Mar Del Plata, Argentina, 7600 Hosp Provincial D. Centenarios; Oncology Dept Rosario, Argentina, S2002KDS CENICLAR Rosario, Argentina Policlínico regional de San Luis San Luis, Argentina Centro Medico San Roque San Miguel de Tucuman, Argentina, T4000IAK Less <<
NCT00772798 Ovarian Cancer Phase 2 Unknown June 2009 Denmark ... More >> Department of Oncology R Recruiting Odense, Denmark, DK-5000 C Less <<
NCT00005962 Leukemia Phase 2 Completed - -
NCT02419495 Advanced Malignant Neoplasm ... More >> Recurrent Malignant Neoplasm Refractory Malignant Neoplasm Less << Phase 1 Recruiting December 31, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Aung Naing    713-563-1930       Principal Investigator: Aung Naing          MD Anderson Regional Care Center-Katy Recruiting Houston, Texas, United States, 77094 Contact: Aung Naing    713-563-1930       Principal Investigator: Aung Naing          MD Anderson Regional Care Center-Bay Area Recruiting Nassau Bay, Texas, United States, 77058 Contact: Aung Naing    713-563-1930       Principal Investigator: Aung Naing          MD Anderson Regional Care Center-Sugar Land Recruiting Sugar Land, Texas, United States, 77478 Contact: Aung Naing    713-563-1930       Principal Investigator: Aung Naing          MD Anderson Regional Care Center-The Woodlands Recruiting The Woodlands, Texas, United States, 77384 Contact: Aung Naing    713-563-1930       Principal Investigator: Aung Naing Less <<
NCT02813135 Children, Adolescents and Youn... More >>g Adults With Refractory or Recurrent Malignancies Less << Phase 1 Phase 2 Recruiting January 2022 France ... More >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Birgit Geoerger, MD    1 42 11 4661 ext +33    birgit.geoerger@gustaveroussy.fr    Contact: Xavier Paoletti, MD    1 42 11 6564 ext +33    xavier.paoletti@gustaveroussy.fr    Principal Investigator: Birgit Geoerger, MD          Germany University Children's Hospitalermany Not yet recruiting Heidelberg, Germany Contact: Olaf Witt, MD    6221 56 4555 ext +49    O.Witt@Dkfz-Heidelberg.de    Italy Fondazione IRCCS Istituto Nazionale dei Tumori Not yet recruiting Milan, Italy Contact: Michela Casanova, MD    02 23 90 25 94 ext +39    Michela.Casanova@istitutotumori.mi.it    Netherlands Erasmus MC, Sophia Children's Hospital Not yet recruiting Rotterdam, Netherlands Contact: Michel Zwaan, MD    10 703 6691 ext +31    c.m.zwaan@erasmusmc.nl    Spain Unidad de Oncología Pediátrica Hospital Niño Jesús Not yet recruiting Madrid, Spain, 28009 Contact: Francisco Bautista, MD    915 035 900 ext +43    franciscojose.bautista@salud.madrid.org    United Kingdom Pediatric and Adolescent Oncology The Royal Marsden Hospital Not yet recruiting Sutton, United Kingdom Contact: Lynley Marshall, MD    208 661 3678 ext +44    Lynley.Marshall@icr.ac.uk Less <<
NCT03257267 Recurrent or Metastatic, Plati... More >>num-refractory Cervical Cancer Less << Phase 3 Recruiting June 7, 2023 -
NCT01222936 Small Cell Lung Carcinoma Phase 2 Completed - Germany ... More >> Klinik für Onkologie und Haematologie Frankfurt am Main, Germany, 60488 Klinikum Kassel Innere Medizin Kassel, Germany, 34125 Italy Azienda Ospedaliera "S. G. Moscati" Avellino, AV, Italy, 83100 Istituto Nazionale Ricerca sul Cancro Genova, GE, Italy, 16132 U.O. di Oncologia Medica Palermo, PA, Italy, 90141 Ospedale Maggiore di Parma Parma, PR, Italy, 43100 Azienda Ospedaliera San Camillo Forlanini Rome, RM, Italy, 00151 Az. San. Ospedaliera Molinette S. Giovanni Battista di Torino Torino, TO, Italy, 10126 Less <<
NCT01704716 Neuroblastoma Phase 3 Recruiting September 2024 -
NCT01752517 - Unknown December 2015 China, Beijing ... More >> Department of Respiratory Medicine, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039 ext +86    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206 ext +86    pumchzj@sina.com    Sub-Investigator: Wei Zhong, MD          Sub-Investigator: Jinmei Luo, MD Less <<
NCT03089892 - Recruiting December 31, 2018 Taiwan ... More >> Tri-Service General Hospital Recruiting Taipei, Taiwan Contact: Cheng-Chang Chang, M.D., Ph.D.          Principal Investigator: Cheng-Chang Chang, M.D., Ph.D.          Sub-Investigator: Mu-Hsien Yu, M.D., Ph.D.          Sub-Investigator: Yu-Chi Wang, M.D., Ph.D.          Sub-Investigator: Salvatore Giovanni Vitale, M.D. Less <<
NCT01832298 Advanced Solid Tumor Phase 1 Completed - China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 China, Heilongjiang The tumor hospital affiliated to Harbin medical university Harbin, Heilongjiang, China, 150000 China, Sichuan West China Hospital, Sichuan University Chengdu, Sichuan, China, 610000 Less <<
NCT01652079 Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT01748019 Solid Tumors Phase 1 Completed - -
NCT01872416 Small Cell Lung Cancer Phase 2 Unknown May 2015 China, Guangdong ... More >> he First Affiliated Hospital of Guangzhou Medical College Recruiting Guangzhou, Guangdong, China, 510120 Contact: Jianxing He, MD    +86-20-83062808    hejx@vip.163.com    Contact: Yalei Zhang, Master    +86-20-83062821    yayazhang2004@163.com Less <<
NCT02945852 Small Cell Lung Cancer Phase 2 Unknown December 2018 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Yun Fan, MD    0086-571-88122192    fanyun@csco.org.cn    Principal Investigator: Yun Fan, MD Less <<
NCT00567567 - Completed - -
NCT00567567 Localized Resectable Neuroblas... More >>toma Localized Unresectable Neuroblastoma Recurrent Neuroblastoma Regional Neuroblastoma Stage 4 Neuroblastoma Stage 4S Neuroblastoma Less << Phase 3 Completed - -
NCT01159327 Small Cell Lung Cancer Phase 2 Terminated(low enrolling parti... More >>cipants) Less << - Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of Less <<
NCT02502266 Deleterious BRCA1 Gene Mutatio... More >>n Deleterious BRCA2 Gene Mutation Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube Serous Adenocarcinoma Fallopian Tube Transitional Cell Carcinoma Fallopian Tube Undifferentiated Carcinoma Ovarian Clear Cell Adenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Seromucinous Carcinoma Ovarian Serous Adenocarcinoma Ovarian Transitional Cell Carcinoma Ovarian Undifferentiated Carcinoma Primary Peritoneal Serous Adenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 2 Phase 3 Suspended(Scheduled Interim Mo... More >>nitoring) Less << - -
NCT00499616 - Completed - -
NCT00739830 Endometrial Cancer Phase 2 Completed - -
NCT00499616 Neuroblastoma Phase 3 Completed - -
NCT00011986 Primary Peritoneal Carcinoma ... More >> Stage III Ovarian Cancer Stage IV Ovarian Cancer Less << Phase 3 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00583622 - Terminated(Slow Accrual) - -
NCT00744081 AML Phase 2 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany Less <<
NCT00583622 Ovarian Cancer Phase 2 Terminated(Slow Accrual) - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01593228 Solid Tumors Phase 3 Completed - -
NCT01756989 Brainstem Glioma Phase 2 Completed - Finland ... More >> Div of Hem/Onc and SCT, Children's Hospital, HUCH Helsinki, Finland, 00029 Less <<
NCT02364713 Fallopian Tube Transitional Ce... More >>ll Carcinoma Malignant Ovarian Clear Cell Tumor Malignant Ovarian Endometrioid Tumor Malignant Ovarian Serous Tumor Ovarian Seromucinous Carcinoma Ovarian Transitional Cell Carcinoma Primary Peritoneal Serous Adenocarcinoma Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Undifferentiated Fallopian Tube Carcinoma Undifferentiated Ovarian Carcinoma Less << Phase 2 Recruiting February 2025 United States, Arizona ... More >> Mayo Clinic Recruiting Phoenix, Arizona, United States, 85054 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: John K. Camoriano, M.D.          United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States, 32224 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Gerardo Colon-Otero, M.D.          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Evanthia Galanis, M.D.          Sub-Investigator: Matthew S. Block, M.D. Less <<
NCT00004188 Neuroblastoma Phase 3 Completed - -
NCT00422682 Tumors Phase 1 Completed - United States, Connecticut ... More >> Research Site New Haven, Connecticut, United States United States, Michigan Research Site Detroit, Michigan, United States United States, New York Research Site New York City, New York, United States United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States United States, Texas Research Site Houston, Texas, United States Research Site San Antonio, Texas, United States Less <<
NCT00011986 - Completed - -
NCT01798004 - Suspended(CRM 31684 - CTEP PIO... More >> requested) Less << - -
NCT00901238 Retinoblastoma Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Medical College of Cornell University New York, New York, United States, 10065 Less <<
NCT02114229 Malignant Rhabdoid Tumor ... More >> Atypical Teratoid Rhabdoid Tumor Less << Phase 2 Recruiting May 2027 United States, California ... More >> Children's Hospital of Los Angeles Withdrawn Los Angeles, California, United States, 90027 Lucille Packard Children's Hospital at Stanford University Medical Center Recruiting Palo Alto, California, United States, 94304 Contact: Sonia Partap, MD    650-723-0993    spartap@stanford.edu    Principal Investigator: Sonia Partap, MD          Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: John Crawford, MD, MS    858-576-1700    jcrawford@rchsd.org    Principal Investigator: John Crawford, MD, MS          United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Kathleen Dorris, MD    720-777-6672    kathleen.dorris@childrenscolorado.org    Principal Investigator: Kathleen Dorris, MD          United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Lindsay B. Kilburn, MD    202-476-2800    lkilburn@childrensnational.org    Principal Investigator: Lindsay B. Kilburn, MD          United States, Florida UF Cancer Center at Orlando Health Recruiting Orlando, Florida, United States, 32806 Contact: Amy A. Smith, MD    321-841-7246    amy.smith@orlandohealth.com    Principal Investigator: Amy A. Smith, MD          United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Sindy Moon    404-785-1441    cindy.moon@choa.org    Contact: Jaclyn Smith    404-785-0692    jaclyn.smith@choa.org    Principal Investigator: Dolly Aguilera, MD          United States, Minnesota Children's Hospital and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55102 Contact: Anne Bendel, MD    651-220-6732    anne.bendel@childrensmn.org    Principal Investigator: Anne Bendel, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tabatha E. Doyle, RN    901-595-2544    tabatha.doyle@stjude.org    Principal Investigator: Santhosh Upadhyaya, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Patricia Baxter, MD    832-824-1000    pabaxter@txch.org    Principal Investigator: Patricia Baxter, MD          United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Sarah Leary, MD    866-987-2000    sarah.leary@seattlechildrens.org    Principal Investigator: Sarah Leary, MD Less <<
NCT00002734 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 1 Completed - United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 Less <<
NCT01798004 Disseminated Neuroblastoma ... More >> Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Regional Neuroblastoma Stage 4S Neuroblastoma Less << Not Applicable Suspended(CRM 31684 - CTEP PIO... More >> requested) Less << October 2018 -
NCT00602667 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Active, not recruiting April 30, 2023 United States, California ... More >> Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 Rady Children's Hospital San Diego, California, United States, 92123 United States, Minnesota Children's Hospitals and Clinics of Minnesota - St. Paul Saint Paul, Minnesota, United States, 55102 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Australia, Queensland Lady Cilento Children's Hospital, Brisbane Brisbane, Queensland, Australia, 4029 Less <<
NCT03632798 Recurrent Ovarian Cancer Phase 3 Recruiting January 31, 2022 United States, Mississippi ... More >> Univeristy of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 Contact: Kelly J Wilkinson, MD    888-815-2005    kjeanes@umc.edu    United States, West Virginia Charleston Area Medical Center Recruiting Charleston, West Virginia, United States, 25326 Contact: Stephen Bush, MD    304-925-4200       Contact: Tina Garten, RN    304-388-9995    Tina.Garten@camc.org    Edwards Comprehensive Cancer Center - Cabell Huntington Hospital Recruiting Huntington, West Virginia, United States, 25705 Contact: Nadim Bou Zgheib, MD    304-399-6600    zgheib@marshall.edu    Contact: Barbara Payne, RN    304-399-6617    Barbara.Payne@chhi.org Less <<
NCT00657878 Ovarian Cancer Phase 3 Unknown June 2017 Belgium ... More >> AZ Groeninge Kortrijk, Belgium UZ Gasthusiberg Leuven, Belgium CHC-Clinique St-Joseph Liège, Belgium Clinique & Maternité Sainte-Elisabeth Namur, Belgium AZ Nikolaas Sint Niklaas, Belgium Germany Charité Campus Virchow-Klinkum Berlin, Germany Kliniken essen Mitte-Evang Huyssens Stiftung/Knappschaft Essen, Germany Universitatsklinikum Essen, Germany Universitatsklinikum Freiburg, Germany Gynecology, Albertinen Krankenhaus Hamburg, Germany Universitatskilinikum Schleswig-Holstein Kiel, Germany Frauenklinik Marburg, Germany Klinikum rechts der Isar der Technischen Universitat Munchen, Germany Italy Azienda Ospedaliera V. Cervello Palermo, PA, Italy Ospedale S. Massimo, Day Hospital Oncologico Penne, PE, Italy, 65017 Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C Aviano, PN, Italy, 33081 Ospedale Mazzoni Ascoli Piceno, Italy Policlinico Universitario Bari, Italy Universita di Bari Policinico I Clinical Ostetrica e Ginecologica Bari, Italy Ospedale Fatebenefratelli Benevento, Italy Ospedale Senatore Antonio Perrino Brindisi, Italy Universita Cattolica del Sacro Cuore Campobasso, Italy Ospedale Renzetti di Lanciano Lanciano, Italy Ospedale A. Manzoni Lecco, Italy Istituto Romagnolo per lo Studio e la Cura dei Tumori Meldola, Italy Istituto Europeo di Oncologia Milano, Italy Ospedale San Raffaele Milano, Italy Ospedale S. Gerardo Monza, Italy Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Uro-Ginecologico Napoli, Italy, 80131 Ospedale Silvestrini Perugia, Italy Ospedale Civile S. Spirito Pescara, Italy A.O. Bianchi Melacrino Morelli Ospedale Riuniti Reggio Calabria, Italy Arcispedale S. Maria Nuova Reggio Emilia, Italy Ospedale degli Infermi, U.O. Oncologia Medica Rimini, Italy Ospedale S. Giovanni Calibita Fatebenefratelli, UO di Oncologia Roma, Italy Universita Cattolica del Sacro Cuore Roma, Italy A.O. Ordine Mauriziano Torino, Italy Ospedale S. Chiara Trento, Italy A.O. di Udine S. Maria della Misericordia Udine, Italy Ospedale Del Ponte Varese, Italy Less <<
NCT01849874 Low-grade Serous Ovarian Cance... More >>r Low-grade Serous Fallopian Tube Cancer Low-grade Serous Peritoneal Cancer Less << Phase 3 Active, not recruiting September 2019 -
NCT00002515 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Head and Neck Cancer Kidney Cancer Liver Cancer Lymphoma Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma Testicular Germ Cell Tumor Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00001335 Ewing's Sarcoma ... More >> Neuroblastoma Rhabdomyosarcoma Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT02631876 Epithelial Ovarian Cancer ... More >> Primary Peritoneal Carcinoma Fallopian Tube Cancer Ovarian Cancer Less << Phase 3 Active, not recruiting February 2019 -
NCT00004060 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00533299 Ovarian Cancer Phase 3 Unknown December 2009 Mexico ... More >> Instituto Nacional de Cancerologia Recruiting Mexico City, Tlalpan, Mexico, 14080 Principal Investigator: Dolores Gallardo, MD Less <<
NCT01121406 - Completed - -
NCT02822157 Ovarian Epithelial Cancer Phase 2 Recruiting May 2019 Belgium ... More >> UZLeuven Recruiting Leuven, Belgium Contact: Ignace Vergote    +32 16 34 74 19    joke.deroover@uzleuven.be Less <<
NCT01121406 Ovarian Neoplasms Phase 2 Completed - Belgium ... More >> 1230.18.32003 Boehringer Ingelheim Investigational Site Brussel, Belgium 1230.18.32004 Boehringer Ingelheim Investigational Site Edegem, Belgium 1230.18.32002 Boehringer Ingelheim Investigational Site Gent, Belgium 1230.18.32001 Boehringer Ingelheim Investigational Site Leuven, Belgium France 1230.18.3321A Boehringer Ingelheim Investigational Site Angers Cedex 9, France 1230.18.3307A Boehringer Ingelheim Investigational Site Bordeaux cedex, France 1230.18.3301A Boehringer Ingelheim Investigational Site Caen, France 1230.18.3322A Boehringer Ingelheim Investigational Site Lille Cedex, France 1230.18.3313A Boehringer Ingelheim Investigational Site Lyon, France 1230.18.3312A Boehringer Ingelheim Investigational Site Nantes cedex 02, France 1230.18.3308A Boehringer Ingelheim Investigational Site Nice cedex, France 1230.18.3314A Boehringer Ingelheim Investigational Site Paris Cedex 20, France 1230.18.3302A Boehringer Ingelheim Investigational Site Paris, France 1230.18.3309A Boehringer Ingelheim Investigational Site Pierre-Bénite cedex, France 1230.18.3305A Boehringer Ingelheim Investigational Site Reims cedex, France 1230.18.3320A Boehringer Ingelheim Investigational Site Saint-Brieuc cedex, France 1230.18.3311A Boehringer Ingelheim Investigational Site Strasbourg, France 1230.18.3310A Boehringer Ingelheim Investigational Site Toulouse Cedex 9, France 1230.18.3315A Boehringer Ingelheim Investigational Site Vandoeuvre les Nancy cedex, France Slovakia 1230.18.42101 Boehringer Ingelheim Investigational Site Bratislava, Slovakia 1230.18.42103 Boehringer Ingelheim Investigational Site Poprad, Slovakia Spain 1230.18.34006 Boehringer Ingelheim Investigational Site Badalona, Spain 1230.18.34001 Boehringer Ingelheim Investigational Site Barcelona, Spain 1230.18.34005 Boehringer Ingelheim Investigational Site Barcelona, Spain 1230.18.34007 Boehringer Ingelheim Investigational Site Girona, Spain 1230.18.34004 Boehringer Ingelheim Investigational Site L'Hospitalet de Llobregat, Spain 1230.18.34002 Boehringer Ingelheim Investigational Site Madrid, Spain 1230.18.34003 Boehringer Ingelheim Investigational Site Madrid, Spain Sweden 1230.18.46005 Boehringer Ingelheim Investigational Site Linköping, Sweden 1230.18.46001 Boehringer Ingelheim Investigational Site Stockholm, Sweden 1230.18.46003 Boehringer Ingelheim Investigational Site Uppsala, Sweden Less <<
NCT00532818 Metastatic Cervical Cancer Phase 3 Unknown December 2010 Mexico ... More >> Instituto Nacional de Cancerologia Recruiting Mexico City, Distrito Federal, Mexico, 14080 Principal Investigator: Lucely Cetina, MD Less <<
NCT00976911 Ovarian Cancer Phase 3 Completed - -
NCT00976911 - Completed - -
NCT00881166 Malignant Disease Phase 1 Completed - United States, Arizona ... More >> Premiere Oncology Scottsdale, Arizona, United States, 85258 United States, California Premiere Oncology Santa Monica, California, United States, 90404 United States, Texas Audie Murphy Veterans Memorial Hospital (VA) San Antonio, Texas, United States, 78229 CTRC at the UT Health Science Center at San Antonio San Antonio, Texas, United States, 78229 South Texas Accelerated Research Therapy (START) San Antonio, Texas, United States, 78229 Less <<
NCT02903004 Ovarian Neoplasms Phase 3 Recruiting April 2020 Italy ... More >> Domenica Lorusso Recruiting Milan, Italy, 20133 Contact: Domenica Lorusso, MD    +390223903697    domenica.lorusso@istitutotumori.mi.it    Contact: Elisa Grassi    +390223903818    elisa.grassi@istitutotumori.mi.it Less <<
NCT00003194 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Unknown - United States, Washington ... More >> Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT02866370 Ovarian Clear Cell Carcinoma ... More >> Endometrial Clear Cell Carcinoma Less << Phase 2 Recruiting March 2021 United Kingdom ... More >> Beatson West of Scotland Cancer Centre Recruiting Glasgow, Lanarkshire, United Kingdom, G12 0YN Contact: Ros Glasspool          Principal Investigator: Ros Glasspool          Sub-Investigator: Iain McNeish          Ninewells Hospital Recruiting Dundee, Tayside, United Kingdom Principal Investigator: Michelle Ferguson          Clatterbridge Cancer Centre Recruiting Liverpool, Wirral, United Kingdom Principal Investigator: Rosemary Lord          Belfast City Hospital (Northern Ireland Cancer Centre) Recruiting Belfast, United Kingdom Principal Investigator: Sarah McKenna          Bristol Heamatology and Cancer Centre Recruiting Bristol, United Kingdom Principal Investigator: Axel Walther          Velindre Hospital Recruiting Cardiff, United Kingdom Principal Investigator: Rachel Jones          Kent & Canterbury Hospital Recruiting Kent, United Kingdom Principal Investigator: Justin Waters          Queen Elizabeth Queen Mother Hospital Recruiting Kent, United Kingdom Principal Investigator: Justin Waters          William Harvey Hospital Recruiting Kent, United Kingdom Principal Investigator: Justin Waters          St James Hospital Recruiting Leeds, United Kingdom Principal Investigator: Geoff Hall          Guy's Hosital Recruiting London, United Kingdom Principal Investigator: Ana Montes          Royal Marsden Hospital Recruiting London, United Kingdom Principal Investigator: Susannah Bannerjee          St Bartholomew's Hospital Not yet recruiting London, United Kingdom Principal Investigator: Melanie Powell          University College London Hospital Not yet recruiting London, United Kingdom Principal Investigator: Jonathan Ledermann          The Christie Hospital Recruiting Manchester, United Kingdom Principal Investigator: Andrew Clamp          Great Western Hospital Recruiting Swindon, United Kingdom Principal Investigator: Omar Khan          Musgrove Park Hospital Recruiting Taunton, United Kingdom Principal Investigator: Clare Barlow Less <<
NCT03367182 - Recruiting August 31, 2018 Korea, Republic of ... More >> Severance hospital Recruiting Seoul, Korea, Republic of, 03722 Contact: Jung-Yun Lee    82-2-2228-2230    jungyunlee@yuhs.ac Less <<
NCT00003944 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00003943 Carcinoma of Unknown Primary ... More >> Lung Cancer Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00618813 Ewing Sarcoma of Bone ... More >> Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Monrovia, California, United States, 91016 Less <<
NCT00004221 Malignant Ovarian Mixed Epithe... More >>lial Tumor Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Primary Peritoneal Carcinoma Stage III Ovarian Cancer Undifferentiated Ovarian Carcinoma Less << Phase 2 Terminated - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00005612 Ovarian Cancer Phase 1 Phase 2 Terminated(Low accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00135135 Neuroblastoma Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00618813 - Completed - -
NCT06425419 Proliferative Vitreoretinopath... More >>y|Proliferative Vitreo-Retinopathy|Rhegmatogenous Retinal Detachment Less << PHASE1 NOT_YET_RECRUITING 2026-03-01 -
NCT00102375 Ovarian Cancer PHASE3 COMPLETED 2025-10-04 Gynecologic Hospital of the Me... More >>dical Facilities RWTH, Aachen, 52074, Germany|Clinic for Gynecology and Gyn. Oncology, Humboldt University, Berlin, 10117, Germany|University Clinic Carl Gustav Carus, Gynecological hospital, Dresden, 01307, Germany|Gynecologic Hospital, Duesseldorf, 40217, Germany|University Gynecologic Hospital, Duesseldorf, 40225, Germany|University Gynecologic Hospital, Frankfurt, 60596, Germany|Gynecologic Clinic of the Ernst-Moritz-Arndt-University, Greifswald, 17487, Germany|University Gynecologic Hospital, G?ttingen, 37075, Germany|Gynecological Clinic of the Medical University, Hannover, 30659, Germany|St. Vincentius Gynecologic Hospital, Karlsruhe, 76137, Germany|University Clinic Schleswig-Holstein, Campus Kiel, Clinic for gynecology and obstetrics, Kiel, 24105, Germany|Otto-von-Guericke University, University Gynecological Hospital, Magdeburg, 39108, Germany|University Gynecologic Hospital Grosshadern, Muenchen, 81377, Germany|University Gynecologic Hospital "rechts der Isar", Muenchen, 81675, Germany|Clinic for Gynecology, Muenster, 48149, Germany|University Gynecologic Hospital, Tuebingen, 72076, Germany|University Gynecological Hospital, Ulm, 89075, Germany|Clinic for Gnyecology and gyn. Oncology HSK, Wiesbaden, 65199, Germany Less <<
NCT06666712 Brain Tumor, Recurrent|Maligna... More >>nt Glioma (WHO Grade III or IV)|IDH1/IDH2 Mutation Less << PHASE1 NOT_YET_RECRUITING 2025-06-28 Columbia University Irving Med... More >>ical Center / NewYork-Presbyterian Hospital, New York, New York, 10032, United States Less <<
NCT00295243 Advanced Solid Malignancies PHASE1 COMPLETED 2025-11-06 Mayo Clinic, Rochester, Minnes... More >>ota, 55905, United States Less <<
NCT00460876 Retinoblastoma PHASE1 COMPLETED 2025-04-08 Hospital JP Garrahan, Buenos A... More >>ires, CF, C1245AAL, Argentina Less <<
NCT05083000 COVID-19 Respiratory Infection PHASE1 UNKNOWN 2022-03-31 Christian Medical College, Vel... More >>lore, Tamil Nadu, 632004, India Less <<
NCT00193388 Lung Cancer PHASE2 COMPLETED 2025-02-07 -
NCT03927274 Glioma of Brain EARLY_PHASE1 TERMINATED 2023-05-24 Moffitt Cancer Center, Tampa, ... More >>Florida, 33612, United States Less <<
NCT00002395 HIV Infections|Leukoencephalop... More >>athy, Progressive Multifocal Less << PHASE2 COMPLETED - Veteran's Administration Hosp ... More >>/ West LA, Los Angeles, California, 90073, United States|HIV Institute / Davies Med Ctr, San Francisco, California, 94114, United States|Univ of Miami, Miami, Florida, 33136, United States|Johns Hopkins Univ, Baltimore, Maryland, 21287, United States|Albany Med College / Div of HIV Medicine, Albany, New York, 12208, United States Less <<
NCT00193401 Lung Cancer PHASE2 COMPLETED 2025-11-04 -
NCT00193167 Colon Cancer PHASE2 COMPLETED 2025-04-06 Tennessee Oncology, Nashville,... More >> Tennessee, 37203, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.37mL

0.47mL

0.24mL

11.86mL

2.37mL

1.19mL

23.73mL

4.75mL

2.37mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories